










Follow this and additional works at: https://tigerprints.clemson.edu/all_theses
Part of the Environmental Engineering Commons
This Thesis is brought to you for free and open access by the Theses at TigerPrints. It has been accepted for inclusion in All Theses by an authorized
administrator of TigerPrints. For more information, please contact kokeefe@clemson.edu.
Recommended Citation
Wang, Han, "EVALUATION OF BIOAUGMENTATION STRATEGIES TO TREAT HIGH CONCENTRATIONS OF
CHLOROFORM AND CARBON TETRACHLORIDE" (2011). All Theses. 1253.
https://tigerprints.clemson.edu/all_theses/1253
 







EVALUATION OF BIOAUGMENTATION STRATEGIES TO TREAT HIGH 









In Partial Fulfillment 
of the Requirements for the Degree 
Master of Science 









Dr. David L. Freedman, Committee Chair 
Dr. Cindy Lee 
















Halogenated methanes, including carbon tetrachloride (CT) and chloroform (CF), 
are significant groundwater contaminants.  Options for bioremediation of high 
concentrations are limited.  Previous studies have shown that an enrichment culture 
(designated DHM-1) that grows on corn syrup has the potential for use in 
bioaugmentation.  DHM-1 cometabolically biotransforms high concentrations of CT and 
CF to nontoxic end products (mainly CO, CO2, and organic acids) in the presence of 
vitamin B12 (approximately 3% of chlorinated methanes on a molar basis).  Sulfide is also
required by this culture to function properly. However, insufficient data are available on 
its performance under field conditions.  Also, it is not yet known how this culture would 
perform at low pH levels that may exist in situ, and how the rate of CF biodegradation is 
influenced by the concentration of B12.   
The objectives of this study were 1) to evaluate biostimulation (usi g corn syrup 
with and without B12) and bioaugmentation as approaches to treat CT and CF; 2) to 
evaluate the effectiveness of an enrichment culture (developed during this study) that 
anaerobically grows on DCM as its sole carbon and energy source, fo  biodegradation of 
DCM produced during reaction of CT and CF with zero valent iron (ZVI); 3) to 
determine the effect of B12 concentration on the rate of CF dechlorination by the DHM-1 
enrichment culture; and 4) to determine the effect of pH on the rate of CF transformation 
by the DHM-1 enrichment culture.  
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To address the first two objectives, microcosms were prepared with subsurface 
material and groundwater from two industrial sites (Sites A and B) contaminated with 
high concentrations of CT and CF. To address the other objectives, the DHM-1 culture 
was subjected to various pH levels and B12 concentrations.   
The results obtained from the microcosm experiment conducted for Site A 
indicated that addition of ZVI followed by bioaugmentation was the most promising 
approach evaluated for removal of CT and CF from the high concentration part of the 
plume (i.e., in the source zone).  This strategy achieved complete removal of CT, nearly 
complete removal of CF and partial removal of the DCM that accumulated during 
reaction of the CT and CF with ZVI.  There is still a need to determine if the other 
volatile compounds formed during reaction with ZVI pose a concern for downgradient 
remediation.  Biostimulation with corn syrup plus B12 was effective for removal of CT 
and almost all of the CF from the medium concentration plume.  Bioaugmentation did not 
improve the rate of transformation; however, addition of DHM-1 ensured complete 
removal of CF.  SDC-9 (a commercially available bioaugmentation culture) and a sulfate-
reducing enrichment culture (developed for use in this study) wereless effective for 
removal of CT and CF in the medium concentration microcosms.   
An anaerobic enrichment culture that grows on DCM as its sole carbon and 
energy source was successfully developed.  It was acclimated to consume up to 500 mg/L 
of DCM.  Use of the culture for bioaugmentation to remove DCM, in Site A microcosms 
treated with ZVI, was partially effective; additional work is needed to optimize the use of 
the culture.  Although ZVI plus bioaugmentation removed CT and CF at a faster rate, the 
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accumulation of DCM was a concern that was only partially addressed by 
bioaugmentation with the DCM enrichment culture.   
For the Site A low concentration plume, biostimulation with corn syrup pl s B12 
was the most promising approach evaluated for removal of CT and CF.  Adjusting the pH 
of the groundwater improved the rate of transformation, although this must be weighed 
against the cost of in situ pH adjustment.  No attempt was made to remove the low level 
of DCM present in the low concentration plume.   
The results of the microcosm experiment performed for Site B indicated 
biostimulation with corn syrup was effective in removing CT; however, addition of B12 
and bioaugmentation did not appreciably enhance the rate or extent of CT 
biodegradation.  Biostimulation and bioaugmentation did not improve the rate of CF 
removal over the unamended treatment.  The rate of CF removal was s ow and consistent 
in the biotic treatments.  None of the amendments were effective in r moving DCM, 
although it was present at a lower concentration than CT and CF.  Attempts to stimulate 
the effectiveness of B12 and bioaugmentation by generating sulfide via sulfate reduction 
were not effective.  Although 12 mM of sulfate was consumed in the treatment 
bioaugmented with DHM-1, there was no enhancement in the rate or extent of CT or CF 
biodegradation.  This suggests that the subsurface material has a considerable sulfide 
demand that needs to be satisfied before the effectiveness of B12 and DHM-1 can be 
realized. 
The results from the experiments conducted to further characterize he DHM-1 
enrichment culture indicated that the maximum CF biodegradation rates for DHM-1 
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increased with increasing pH from 5.0 to 7.7. Its activity is severely inhibited by pH 
levels below 6.0. At pH 5.0, it lost its ability to biotransform CF. Between pH 6.4 and 
7.3, the rate of CF biodegradation by DHM-1 is somewhat stable; however, it increases 
rapidly between pH 7.3 and 7.7. Given the inhibitory effect of pH levels b ow 6.0, the 
pH of the groundwater should be adjusted within the neutral range for succes ful 
bioaugmentation to occur.  The sensitivity of DHM-1 to low pH values must be 
considered for application in aquifers that have pH levels below 6.  With respect to the 
dose of B12, CF biodegradation rates for DHM-1 increased with increasing vitamin B12 
concentrations. The relationship between the B12 to CF ratio and the rate of CF 
biodegradation can be described by a modification of the Michaelis-Mnten kinetics 
model. A Vmax of 66±4.6 mg CF/L·d and a B12/Km ratio of 0.0050±0.0010 mol B12 per 
mol CF were obtained from fitting experimental results to this model. This information 
can help in the selection of a cost-effective dose for B12 when it is used as an amendment 
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1.0 INTRODUCTION AND BACKGROUND 
 
Carbon tetrachloride (CT) and chloroform (CF) are ubiquitous environmental 
pollutants that are frequently detected in soil and groundwater. Both chemicals are toxic 
and have similar adverse health effects. According to the Material Safety Data Sheets of 
these two compounds, chronic exposure to CT or CF can both cause liver and kidney 
damage and affect the central nervous system. Birth defects may be caused by inhalation 
or ingestion of CF.  And both compounds are group 2B carcinogens, meaning they are 
“possibly carcinogenic to humans,” according to the International Agency for Research 
on Cancer (27). Their contamination is prevalent because both chemicals were heavily 
used in industrial applications (8, 19). 
CT is a volatile chlorinated solvent which has been used widely over decades as a 
degreasing agent, as a pesticide, as a precursor to synthesis of freons, for dry cleaning and 
in fire extinguishers (8). Like CT, CF is also a volatile chlorinated solvent which has a 
myriad of applications including production of pesticides, extracting pharmaceutical 
material as a solvent and serving as a precursor in the making of freons. CF also was one 
of the first surgical anesthetics (19). Use of CT was banned in 1970 in consumer products 
in the U.S., followed by a complete ban in 1996 by the Montreal protocol (43) due to its 
deleterious effects on the stratospheric ozone layer and use and emission of CF is also 
tightly controlled now due to its toxicity (19). Widespread use of CT and CF combined 
with historically poor disposal practices, spills and leaks from underground storage tanks, 
and recalcitrance to biodegradation has led to substantial soil and groundwater 
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contamination. According to the 2007 “Comprehensive Environmental Response, 
Compensation, and Liability Act Priority List of Hazardous Substances,” CF ranks 
eleventh overall on this list and is the third highest among chlorinated organics after vinyl 
chloride and polychlorinated biphenyls. Although not ranked as highly, CT is also listed 
(1). 
Even though the remediation of aquifers contaminated by these pollutants has 
received much attention, efficient strategies to treat CT and CF are still lacking. With an 
estimated half-life for abiotic hydrolysis of 7000 years and 1.3-3500 years in water at 
20oC, respectively, for CT and CF (46), both compounds are highly persistent in 
groundwater. When mediated by natural inorganic reductants like Fe(II) or man-made 
inorganic reductants like zero valent iron (ZVI), CT and CF may undergo rapid abiotic 
reductive transformation. But when CT or CF are present at high concentrations, less 
chlorinated but still toxic daughter products like CF and dichloromethan (DCM) are 
likely to accumulate in large quantities as a result of abiotic processes (10, 31, 42).  These 
daughter products still need to be treated; bioaugmentation with cultures that dechlorinate 
CF and DCM is an option. However, using ZVI to rapidly initiate the attack on CT is still 
an attractive remediation strategy since most biological methods appear not to be 
effective enough to treat high concentrations of CT, (e.g., in the vicinity of a source zone) 
(10, 32, 42). Successful forms of ZVI application for treatment of chlorinated 
hydrocarbons include permeable reactive barriers and injection of powder or nano-sized 
particles. When reacted with CT and CF, ZVI is able to reduce the contaminants to DCM 
through a reductive dechlorination pathway, or to methane through a reductive 
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elimination pathway, which is more desirable because of the nontoxic product (10, 42).  
However, the factors that control the predominant pathway are not yet clear. 
Aerobic transformation of CT is unfavorable because its carbon is fully oxidized; 
microbial CT degradation has only been observed under lower redox conditions. 
Although aerobic cometabolic transformation of CF is possible, it exerts significant 
toxicity (44). Thus, bioremediation of these halomethanes, especially at mg per liter 
concentrations, appears to be limited to anaerobic transformations. However, CT is 
inhibitory to a variety of anaerobic metabolic processes (7, 12). CF is an even more 
potent inhibitor (47), especially for reductive dechlorination of chlorinated ethenes (33).  
When present at high concentrations, CT and CF are not likely to be transformed quickly 
enough by indigenous microbes due to their inhibitory impacts. Thus, monitored natural 
attenuation is not likely to be feasible for CT and CF when their concentrations are in the 
mg per liter range.   
So far no organisms capable of using CT as a carbon or an energy source have 
been isolated. Nor have any organisms that can chlororespire CT asa terminal electron 
accepter been found, even though the redox potential for the CT/CF couple of +584 mV 
(9) is very favorable. But cultures and strains capable of CT cometabolic degradation 
under anaerobic conditions have been reported widely, including sulfate reducing 
enrichment cultures (15, 39), fermentative enrichment cultures (39) and Pseudomonas 
stutzeri strain KC, which transforms CT under nitrate reducing conditions t innocuous 
end products without CF accumulation (6). For CF, cometabolic transformati n has also 
been observed under a variety of anaerobic conditions (3, 15, 21-22). More recently, a 
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Dehalobacter strain was isolated that is able to metabolically halorespire CF to DCM 
(19). Biostimulation to enhance anaerobic biotransformation of CT and CF has been 
demonstrated with substrates such as methanol (2), fructose (23) and acetate (37). 
However, biostimulation typically results in accumulation of lesser chlorinated daughter 
products like CF and DCM via reductive dechlorination (Figure 1.1).  High levels of 
sulfide favor a substitutive reaction that yields carbon disulfide (CS2).  Although CS2 is 
not a regulated compound in drinking water, it is an undesirable endpoint due to its acute 
toxicity. Addition of cyanocobalamin (vitamin B12) increases the rate of 
biotransformation and shifts the pathway from reductive dechlorination and CS2 
formation towards hydrolytic and substitutive reactions that yield CO, CO2, and organic 
acids (Figure 1.1) (3, 23-24, 39). However, the cost of adding B12 is high and the 
minimum dose required for this cofactor to be effective has not been fully investigated.  
An alternative to external addition of B12 is to grow and harvest B12-producing bacteria 
(e.g., growing on 1,2-propanediol) and then use these microbes to degrade CT and F. 
The ability to produce B12 by the biodegrading microbes would be a substantial 
advantage in terms of cost reduction. Research in this direction has been reported (50), 
although no reports were found for field scale application.   
There are currently no commercial cultures available for bioaugmentation to treat 
CT and CF. Most of the cultures described in the literature are not applicable to 
groundwater remediation or the products formed are not acceptable (i.e., carbon disulfide 
(CS2) from CT or DCM from CF).  In situ biotransformation of CT using Pseudomonas 
stutzeri strain KC is achievable (11) but this microbe needs a high concentration of nitrate 
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as the terminal electron acceptor, a relatively high pH (~8), and the concentration of CT 
that it can tolerate is comparatively low, i.e., less than 5 mg/L. The discovery of a 
Dehalobacter strain capable of respiring CF represents an important breakth ough for CF 
biodegradation (19). However, its end product is DCM; and therefore, another culture 
that consumes DCM is needed to finish the remediation process.   
A fermentative enrichment culture designated DHM-1 which was developed by 
Shan et al. (40) shows promise for biodegrading CT and CF. This culture cometabolically 
transforms high concentrations of CT (8.8 mg/L) and CF (500 mg/L CF) in the presence 
of 3 mol percent of B12 (i.e., 0.03 mol of B12 per mol of CT or CF). In the presence of B12, 
the end products are mainly CO, CO2, and organic acids (39). When provided with corn 
syrup and B12, DHM-1 is able to grow and biodegrade up to 2000 mg/L of CF in 180 
days. It is able to grow on corn syrup at CF concentrations as high as 4000 mg/L 
(approximately one half its aqueous solubility), although CF was not biodegraded (38). 
However, a number of characteristics of DHM-1 have not been fully explored, including 
its ability to function in the field, the extent of its requirement for B12, and the range of 
pH in which it functions.  The main focus of this thesis is to address these issues.  
Before evaluating DHM-1 for bioaugmentation in the field, preliminary 
evaluations were performed in laboratory microcosm studies.  For this thesis, samples 
from two industrial sites were used.  To avoid disclosing information about the sites, they 
were referred to in this thesis as sites A and B.  At Site A, the concentration of CT is up 
to 400 mg/L and the concentration of CF is up to 300 mg/L. At Site B, he concentrations 
of CT and CF are substantial, but lower than for Site A. 
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The concentration of CT (400 mg/L) present at Site A is considered to be highly 
inhibitory to biological processes.  Based on concerns that this may be too high for 
DHM-1, one of the treatments evaluated for this site was addition of ZVI.  Preliminary 
tests indicated that DCM was the main product.  Consequently, an additional ssue for 
this site is development of an enrichment culture that biodegrades DCM to nonhazardous 
products.  Unlike CT and CF, DCM is subject to biodegradation as a sole carbon and 
energy source under anaerobic conditions (13). Cultures that are capable of DCM 
biodegradation have been reported under fermentative and nitrate reducing conditions, 
during which DCM is transformed to nonchlorinated products like CO2 and organic acids 
(13, 17, 28). Although monitored natural attenuation may be effective for DCM 
biodegradation at many contaminated sites, bioaugmentation should be considered if the 
necessary microbes are lacking. 
Another finding from preliminary evaluation of groundwater from Site A was the 
detection of toluene and ethylbenzene at low concentrations (~1 mg/L), along with CT 
and CF. Under anaerobic condition, metabolic degradation of toluene and ethylbenzene 
has been well demonstrated (5, 29, 36). Ethylbenzene can be degraded under nitrate 
reducing, sulfate reducing, and fermentative conditions. Compared to ethylbenzene, 
toluene can undergo transformation even faster under a broader range of terminal lectron 
accepting conditions. Both compounds serve as growth substrates under anaerobic 
conditions. Therefore, complete biodegradation of toluene and ethylbenzene was 
expected after removing the more toxic CT and CF. 
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2.0 RESEARCH OBJECTIVES 
 
The overall objective of this thesis was to evaluate strategies to remediate 
groundwater contaminated with high concentrations of CT and CF, with a focus mainly 
of further characterizing the DHM-1 enrichment culture developed by Shan et al. (40).  
The specific objectives were: 
1) To evaluate biostimulation (using corn syrup with and without B12) and 
bioaugmentation as approaches to treat CT and CF.  Three types of 
bioaugmentation cultures were evaluated for this purpose:   
 DHM-1, for biodegradation of high concentrations of CT and CF; 
 SDC-9, a commercially available bioaugmentation culture that 
exhibits activity on CT and CF; and 
 An enrichment culture of sulfate reducing bacteria (SRB), 
developed over the course of this research, for biodegradation of 
CT and CF 
2) To determine the effect of B12 concentration on the rate of CF dechlorination 
by the DHM-1 enrichment culture;  
3) To determine the effect of pH on the rate of CF transformation by the DHM-
1 enrichment culture; and  
4) To evaluate the effectiveness of an enrichment culture that anaerobically 
grows on DCM as its sole carbon and energy source, developed over the 
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course of this research, for biodegradation of DCM produced during reaction 
of CT and CF with ZVI. 
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3.0 MATERIALS AND METHODS 
 
3.1 Chemicals 
CT (99.9%, Sigma–Aldrich), CF (99.7%, Shelton Scientific), DCM (99.9%, 
AlliedSignal), 1,1-dichloroethene (99%, TCI America), cis-1,2-dichloroethene (99%, TCI 
America), 1,2-dichloroethane (1,2-DCA; 100%, Mallinckrodt), 1,1,2-trichloroethan 
(1,1,2-TCA; 98%, Acros Organics), CS2 (100%, J.T. Baker), benzene (99%, Sigma–
Aldrich), toluene (99%, Fisher Scientific), and ethylbenzene (99%, Alfa esar) were 
obtained as neat liquids. Chloromethane (CM; 99%, Praxair), ethene (99.95%, Airgas), 
ethane (99%, Matheson), and methane (99.99%, Matheson) were obtained as neat 
gases. 1,1-dichloroethane standard (2000 µg/mL, VWR) was obtained as methanol 
solution. Sodium lactate (60% syrup, EM Science) and corn syrup (regular type, 
Sweetener Products Company) were used as electron donors. The chemical oxygen 
demand for corn syrup and sodium lactate was calculated based on their presumed 
composition, i.e., C6H12O6 and C18H32O2, respectively. Cyanocobalamin (i.e., vitamin 
B12, USP grade) was obtained from Research Organics, Inc. Micron scale high reactivity 
ZVI powder was obtained from Hepure Technologies, Inc. All other reagents were ACS 
grade or higher.   
3.2 Analytical Methods 
Halogenated (CT, CF, DCM, CM, 1,1-dichloroethene, 1,2-DCA, and 1,1,2-TCA) 
and nonhalogenated volatile compounds (methane, ethane, ethene, CS2, benzene, ethyl 
benzene, and toluene) were monitored by gas chromatographic analysis of 0.5 mL 
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headspace samples (14). A Hewlett Packard 5890 Series II gas chromatograph (GC) 
equipped with a flame ionization detector and a 2.44 m × 3.175 mm column packed with 
1% SP-1000 on 60/80 Carbopack B (Supelco) was used. A GC response factor for each 
volatile organic compound was measured to relate the total mass of the compound to the 
GC peak area. Results were reported in terms of the µmoles per bottle, in order to easily 
reveal the stoichiometry of the transformations (e.g., moles of CF formed per mole of CT 
transformed). Aqueous phase concentrations are also reported based on partitiing of the 
compounds between the headspace and aqueous phases, as previously described (45). 
The detection limit of this method is lower than the maximum contami nt level (MCL) 
for each of the chlorinated compounds.  Representative response factors for each 
compound are provided in Appendix A. 
Organic acids (acetate, propionate and lactate) were analyzed on a Waters 600E 
HPLC system equipped with a UV/Vis detector (Model 490E) set at 210 nm and an 
Aminex HPX-87H ion exclusion column (300 mm x 7.8 mm; BioRad). Eluant (0.01N 
H2SO4) was delivered at 0.6 mL per min.  Representative response factors for each 
compound are provided in Appendix B.  Samples were removed from microcosms by 
setting them in an upright position, allowing the solids to settle, and then using a glass 
syringe (1 mL) with a long needle to remove 1 mL of the clarified groundwater.  Then 
0.5 mL of the removed groundwater was filtered and discarded using a yringe filter (0.2 
µm, Whatman) to condition the filter. The other 0.5 mL was then filtered and stored in a 
HPLC sample vial until analysis.   
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Sulfate was measured on a Dionex DX-600 ion chromatography system equipped 
with a CD25 Conductivity Detector and a Dionex guard column (AG9-HC, 4 mm x 50 
mm) followed by an IonPac AS9-HC anion-exchange column (4 mm x 250 mm). Eluant 
(9 mM Na2CO3) was delivered at 1.0 mL per min.  A representative response factor is 
provided in Appendix C.  Samples from the microcosms were taken and processed in the 
same manner described above for organic acids.   
3.3 Enrichment Cultures 
Five enrichment cultures were evaluated in the course of this research.  A 
description of each one follows.   
3.3.1 DHM-1 Enrichment Culture 
The DHM-1 enrichment culture developed by Shan (40) was maintained for use 
in this thesis. The enrichment was maintained in two 160 mL serum bottles with 100 mL 
of mineral salts medium (MSM) (the components of the media are shown in Table 3.1) 
plus corn syrup as the electron donor (5 mM), B12 as the catalyst (136 µM) and CF (36 
µL neat = 452 µmol per bottle, or an aqueous phase concentration of 500 mg/L). For 
routine purposes, the molar ratio of B12 to CF was 3%. The headspace of the serum 
bottles was purged with a gas mixture (30% CO2/70% N2) and the serum bottles sealed 
with Teflon-faced red rubber septa and aluminum crimp caps. Headspace an lysis by GC 
was conducted every four to five days. When the remaining CF was below 0.5 mg/L, the 
culture was transferred to fresh medium (5% v/v) along with a new dose of CF, B12 and 
corn syrup. It was expected that approximately one month or less was needed to 
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biodegrade 500 mg/L of CF. The typical behavior of the DHM-1 enrichment culture is 
shown in Figure 3.1. 
3.3.2 SRB Enrichment Culture 
A lactate-grown SRB enrichment culture was started in a 250 mL glass bottle 
containing 200 mL of MSM (Table 3.1), 37.1 mM sulfate, 3 mM sodium lactate and 20 g 
of subsurface material from the high concentration plume of Site A (described below). 
Growth was monitored based on consumption of lactate and production of acetate. When 
the lactate was consumed, more was added. The maximum dose of lactate was kept at 2 
mM to avoid enriching for a fermentative culture that converts lactate to propionate plus 
acetate, rather than a SRB culture. Once a consistent level of lactate consumption and 
acetate production was demonstrated, the enrichment was transferred (1% v/v) to MSM 
after consuming approximately 10 mM lactate without significant propionate formation; 
the culture was then considered ready for use in bioaugmentation. The performance of the 
SRB enrichment culture is shown in Figure 3.2. 
3.3.3 DCM Enrichment Culture 
An enrichment culture that anaerobically consumes DCM as its sole energy and 
carbon source was developed from a previous microcosm study conducted at Cl mson 
University.  DCM at a concentration of 13-15 mg/L was biodegraded in the microcosms 
without accumulation of lesser chlorinated products.  DCM biodegradation in the 
microcosms was enriched by gradually increasing the dose to 500 mg/L. An aliquot from 
the microcosm was then transferred to an anaerobic MSM (Table 3.1) (1% v/v) to begin 
development of a sediment-free enrichment culture.  The culture was used for 
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bioaugmentation of microcosms in which DCM accumulated.  The behavior of the DCM 
enrichment culture is shown in Figure 3.3.   
3.3.4 SDC-9 Enrichment Culture 
A commercially available enrichment bioaugmentation culture (SDC-9) was 
obtained from Dr. Rob Hinchee at Shaw Environmental, Inc..  The culture was used to 
bioaugment selected microcosms immediately upon receipt.   
3.3.5 1,2-DCA  Enrichment Culture 
A dehalorespiring enrichment culture that uses 1,2-DCA as its terminal electron 
acceptor and lactate as its electron donor was added to treatments that received ZVI 
(Table 3.2), based on the presumption that 1,2-DCA had formed during reaction of the 
chlorinated compounds with the chlorinated methanes.  The culture converts 1,2-DCA to 
ethene via dihaloelimination and organohalide respiration; the reaction is carr ed out by 
Dehalococcoides (34, 47).  Additional characteristics of the 1,2-DCA enrichment culture 
are described by Yu (48) and Peethambaram (34).   
3.4 Experimental Design for Microcosms 
The experimental designs used to evaluate bioremediation strategies for Sites A 
and B are described below.  In each case, microcosms were used for the evaluation.   
3.4.1  Site A 
The potential for bioremediation of groundwater contaminated with high 
concentrations of CT and CF at Site A was evaluated using the exp rimental design 
outlined in Table 3.2 and described below.  Along with chlorinated methanes, th  
groundwater also contains acetone, 1,1-dichloroethene, 1,1-dichloroethane, cis-1,2-
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dichloroethene, benzene, toluene and ethyl benzene.  The peak areas for toluene and 
ethylbenzene were one order of magnitude higher than the other compounds and, 
therefore, they were quantified.  For the other compounds, their GC peak ar s were 
recorded but they were not quantified.   
The study consisted of three sets of serum bottles targeting three different levels 
of CT and CF concentrations observed at different locations (Table 3.3) on the site: 
1) High concentration plume (source zone) (CT ~400 mg/L, CF ~340 mg/L); 
2) Medium concentration plume (CT ~50 mg/L, ~CF 20 mg/L); and 
3) Low concentration plume (CT ~5 mg/L, CF ~1-2 mg/L). 
Treatments for the high concentration plume included unamended controls (H-
Con); biostimulation with corn syrup (H-BST); biostimulation with corn syrup plus 
vitamin B12 (H-BB12); bioaugmentation with DHM-1 plus B12 and corn syrup (H-
BIOA); bioaugmentation with a commercial bioaugmentation culture (SDC-9) plus B12 
and lactate (H-BIOB); bioaugmentation with the sulfate-reducing enrichment culture plus 
B12 and lactate (H-BIOC); ZVI followed by bioaugmentation with a DCM-degrading 
enrichment culture (H-ZBIO); autoclaved controls (H-AC); and water controls (H-WC).  
Treatments for the medium concentration plume were the same, but without water 
controls (the higher concentration water controls were considered sufficient to evaluate 
diffusive losses).  The treatment identifiers were modified by replacing the leading “H” 
with “M” (e.g., H-Con was changed to M-Con).     
Treatments for the low concentration plume control included unamended controls 
(L-Con); biostimulation with corn syrup (L-BST); biostimulation with corn syrup plus 
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vitamin B12 (L-BB12); biostimulation with corn syrup plus vitamin B12 along with pH 
adjustment (L-ABST); and autoclaved controls (L-AC).  It was anticipated that 
bioaugmentation would not be needed for the low concentration microcosms.   
All treatments were prepared in triplicate in an anaerobic chamber. All treatments 
except the water controls received subsurface material (composited from multiple core 
samples at varying depths) and groundwater collected from the three locations. The water 
control bottles received distilled deionized water and CT, CF, and DCMin approximately 
the same amounts as in the high concentration groundwater; glass beads were added to 
displace the same volume of water (~11 mL) as the subsurface mterial in the other 
treatments.     
3.4.2  Site B 
Microcosms were also used to assess bioremediation of subsurface material and 
groundwater from Site B, which contains approximately 20 mg/L of CT and 80 mg/L of 
CF. The experimental design for the microcosm experiments for Site B is summarized in 
Table 3.4 and described below, for the following treatments:  Unamended (Con); 
biostimulation (BST) with corn syrup; biostimulation with corn syrup + B12 (BB12); 
bioaugmentation with DHM-1 (BIO) (which includes addition of corn syrup + B12); and 
autoclaved controls (AC).  All treatments were prepared in triplicate. 
3.5 Microcosm Preparation 
3.5.1  Site A 
Subsurface material and groundwater were collected from three locations 
representing the high (source zone), medium and low concentration plumes. For the high 
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concentration part of the plume, subsurface material was collected from the bottom of the 
saprolite zone from a boring near piezometer PZ-95 (approximately 8-10 feet below 
ground surface (bgs)).  For the medium concentration part of the plume, subsurface 
material was collected from the bottom of the saprolite zone at monitoring well TP-1 
(approximately 35-37 feet bgs).  For the low concentration part of the plume, subsurface 
material was collected from the bottom of the saprolite zone from a boring near 
piezometer PZ-12 (approximately 45-47 feet bgs). The subsurface material from TP-1 
and PZ-12 was collected with 2.5 foot-long Shelby tubes which were fill d with about 1 
kg of subsurface material and sealed with wax on both ends. The subsurface material 
from PZ-95 was collected and sealed using a clean bucket from 8-10 feet bgs since the 
density of the subsurface material from this area would crush the Shelby tube, but air 
exposure was minimized. All subsurface material was shipped on ice to Clemson 
University.  
Groundwater samples were collected from piezometer PZ-95-2 (47-52 feet bgs) 
for the high concentration part of the plume, from TP-4 monitoring well (30-40 feet bgs) 
for the medium concentration part of the plume, and from piezometer PZ-12 (49- 54 feet 
bgs) for the low concentration part of the plume.   Samples were shipped to Clemson 
University in brown glass 1 L bottles, on ice, via an overnight carrier, within 24 hours of 
taking the samples.  Samples were stored in a cold room until the microcosms were 
prepared.  
Subsurface material was removed from the Shelby tubes before microcosm 
preparation by using a power saw to cut off a portion of the tube which was filled with 
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wax, so that the wax layer would not contaminate the subsurface material sample. All 
subsurface material was transferred to three containers sterilized with ethanol and stored 
in an anaerobic chamber.  Before setting up the microcosms, groundwater samples were 
transferred to the anaerobic chamber and allowed to warm to room temperature.  
Prior to setting up the microcosms, groundwater samples from each plume were 
evaluated by GC in duplicate in serum bottles containing 50 mL of groundwater and 11 
mL of glass beads (the same volume as used in water controls). Results from this 
evaluation showed that CF was similar to the field conditions (Table 3.3):  246±40, 
27.1±0.2, and 0.28±0.01 mg/L for groundwater from the high, medium and low 
concentration plumes, respectively.  Consequently, no changes were made to th  
groundwater with respect to CF.  However, the CT levels were considerably lower than 
expected (Table 3.3):  36.3±12.9, 22.0±0.02, and 1.38±0.02 for groundwater from the 
high, medium and low concentration plumes, respectively.  Consequently, CT was added 
to the groundwater, either as a saturated water solution (~5.2 µmol/mL) or as a neat 
compound.  The decision of which to add depended on the volume; the lowest volume of 
neat CT added was 3 µL, or 10.4 µmol/bottle; if the amount required was less than that, 
the water-saturated solution was used.  Sufficient CT was added so that the initial 
microcosm concentrations were similar to the field levels (Table 3.3).   
The pH of the groundwater samples was checked before setting up the 
microcosms. The groundwater from the high and medium concentration plumes was 
within the desired range of 6.5-7.5.  However, as corn syrup was fermented to organic 
acids, the pH decreased.  To keep the pH in the range of 6.5 to 7.5, NaOH (8 M) was 
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added periodically.  The groundwater from the low concentration plume was below 6, 
which is often unfavorable for bioremediation.  The pH in the L-ABST treatment (Table 
3.2) was adjusted to 6.6-7.5 using NaOH (8 M), and was maintained in this range 
throughout the incubation period. 
The amount of electron donor added to the appropriate treatments, in the form of 
corn syrup or lactate (Table 3.2), was based on supplying 500 mg/L of chemical oxygen 
demand in excess of the amount needed to reduce sulfate in the groundwater to sulfide.  
The initial concentration of sulfate was 0.89, 3.45 and 0.18 mM, in groundwater from the 
high, medium and low concentration plumes, respectively.  For example, for the high 
concentration microcosms, 77 µL of a corn syrup stock solution containing 360 mg/mL 
of chemical oxygen demand was added, which provided 557 mg/L of chemical oxygen 
demand (or 27.9 mg/bottle).     
Microcosms were prepared in 160 mL serum bottles by adding 20.0±0.2 g of 
subsurface material and 50±1 mL of groundwater, inside an anaerobic chamber.  The 
bottles were then sealed with a Teflon-faced red rubber septum and aluminum crimp cap. 
Resazurin was added to the groundwater to achieve a concentration of 1 mg/L and serve 
as a redox indicator.  Within three days of preparing the microcosms and allowing the 
volatile compounds to equilibrate, the treatments with ZVI were return d to the anaerobic 
chamber, and were opened briefly while 0.2 g of ZVI was added per bottle to achieve a 
one percent weight ratio of ZVI to subsurface material; they wre immediately resealed 
and removed from the chamber.  The microcosms were then placed on a shaker table for 
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24 h to facilitate obtaining equilibrium between the subsurface material and liquid phase 
prior to taking headspace samples for analysis of the volatile compounds.   
The amount of vitamin B12 added was based on a stepwise strategy, since the 
degradation of CT and CF was expected to occur in a stepwise manner (i.e., CT first, then 
CF). Therefore, the first dose of B12 was based on the initial amount of CT and the 
second dose was based on the remaining amount of CF. Both doses were kept at a molar 
ratio of 3% B12 to CT or CF.   
The first bioaugmentation dose and first B12 addition were made after electron 
donor had been added into each bottle and low redox conditions had developed, based on 
a color change in the resazurin from pink to clear. For DHM-1, SDC-9, and the SRB 
enrichment cultures, the volume of the addition was adjusted so that the resulting protein 
concentration in the microcosms was 5 µg/mL:  0.50 mL/bottle for DHM-1, 0.13 
mL/bottle for SDC-9, and 1.0 mL/bottle for the SRB culture. A second dose of the 
bioaugmentation culture (the same volumes listed above) was made once CT was 
consumed and was accompanied by the second dose of B12. For ZVI treatments that 
yielded high amounts of DCM, bioaugmentation with the DCM enrichment culture was 
performed (0.5-1.0 mL/bottle).  Bioaugmentation with SDC-9 or DHM-1 was used to 
facilitate the removal of remaining CF, prior to adding the DCM enrichment culture.  The 
1,2-DCA enrichment culture was added only to the H-ZBIO and M-ZBIO treatments 
(0.50 mL/bottle).   
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3.5.2  Site B 
For Site B, subsurface material was collected from location S-1464-MW08-03S 
and groundwater samples from monitoring well MW-R06-03.  Samples were stored at 
4°C prior to preparing the microcosms.   
Microcosms were set up in the same manner as for Site A, as described above. 
For Site B, however, there was not a ZVI treatment since the concentrations of CF and 
CT at this site were low enough that bioremediation alone was anticip ted to be 
successful.  Only one enrichment culture, DHM-1, was tested for the bioaugmentation 
treatment. A dose of 0.50 mL/bottle was used to achieve a protein concentration of 5 
µg/mL. Two more doses of bioaugmentation were made when observations suggested 
that the first dose did not facilitate transformation of CT and CF. Subsurface material and 
groundwater were collected from only one location at this site. 
Because most of the contaminant mass (CT, CF, DCM, 1,2-DCA and 1,1,2-TCA) 
was destroyed after the AC microcosms were autoclaved, it was necessary to add these 
compounds as neat liquid or saturated water solution to restore the initial concentrations 
to a similar level as in the other treatments. The specific quantities added were: 2  µL of 
CT as neat compound; 335 µL of CF saturated water (~67 µmol/mL); 2 µL of DCM 
saturated water (~235.5 µmol/mL); 29 µL of 1,2-DCA saturated water (~87.8 µmol/mL); 
and 43 µL of 1,1,2-TCA saturated water (~33.7 µmol/mL).  
3.6 Evaluating the Effect of B12 Concentration on CF Biodegradation by DHM-1 
The effect of vitamin B12 concentration on CF transformation rates by DHM-1 
was evaluated in serum bottles as described in Section 3.3.1, except that the concentration 
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of B12 was varied from 0.000 to 0.030 mol B12 per mol of CF added (500 mg CF/L = 4.19 
mM), only one dose of corn syrup was added, and the bottles were continuously mixed 
on a shaker table. Media controls were included to evaluate abiotic losses of CF.  The 
highest CF biodegradation rate for a given B12 dose was determined by linear regression 
of CF concentration versus time.  The results for all B12 doses were fit (using Matlab, 













where V = rate of CF biodegradation (mg/L·d); Vmax = maximum rate of CF 
biodegradation (mg/L·d);  B12/Co = the amount of B12 added (µmol/bottle) divided by the 
amount of CF added (µmol/bottle); and  B12/KM = molar ratio at which V is one half of 
Vmax.   
3.7 Evaluating the Effect of pH on CF Biodegradation by DHM-1 
Biodegradation rates for 500 mg/L of CF by DHM-1 were measured at pH levels 
from 5.0 to 7.7.  B12 (0.030 mol per mol of CF added) and corn syrup (900 mg/L) were 
added to all treatments.  Serum bottles were prepared as described above for the B12 dose 
experiment, with the following modifications.  The MSM was prepared t the target pH 
by varying the amounts of K2HPO4 and KH2PO4 (Appendix D).  After adding sodium 
sulfide, the final pH was adjusted using either H3PO4 (1 M) or NaOH (8 M); the MSM 
was incubated for six days to ensure equilibrium was reached at the target pH, before 
inoculating the DHM-1 enrichment culture (5% v/v).  It was not necessary to sparge the 
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headspace of the bottles with 30% CO2/70%.  Each time CF was analyzed on the GC, the 
pH was measured (0.2 mL sample) and, as needed, increased to the target level using 
NaOH (8 M); decreases in pH were caused by fermentation of the corn syrup to organic 
acids.  The highest CF biodegradation rate at a given pH was determined in the same 
manner described above for varying B12 doses.  Lag times were based on the time from 




4.1 Site A 
4.1.1 High Concentration Plume (CT ≈ 500 mg/L, CF ≈ 250 mg/L) 
Results for the AC and WC treatments are shown in Figures 4.1 and 4.2, 
respectively.  Percent decreases are summarized in Table 4.1.  Over an incubation period 
of 577 days, the losses in the autoclaved controls for the C1 compounds (CT, CF, DCM 
and CS2) ranged from 24 to 29%, while losses for toluene (52%), and ethylbenzene 
(59%) were approximately twice as high.  In the water controls, CT decreased by 28%, 
CF by 36%, and DCM by 21%, most likely via diffusion. Overall, these r ults indicate 
that losses from the abiotic controls were acceptable given the long incubation time, 
when compared to the magnitude of losses in several of the activetreatments (described 
below).   
The unamended treatment (Figure 4.3) behaved similarly to the AC bottles 
(Figure 4.1), with similar average losses for CT, CF, DCM, CS2, ethylbenzene, and 
toluene (Table 4.1).  This indicated that there was no significant biotic activity in the 
unamended treatment (Student’s t-test, α=0.05), which is consistent with the lack of 
activity observed in the field. 
As shown in Figure 4.4 and Table 4.1, biostimulation with corn syrup alone did 
not significantly improve the removal of CT, CF, DCM, CS2, ethylbenzene, and toluene 
over the unamended controls (Student’s t-test, α=0.05).  Adding B12 along with corn 
syrup also did not significantly improve the rate or extent of halomethane biodegradation 
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(Figure 4.5; Table 4.1; Student’s t-test, α=0.05).  The first dose of B12 was not made until 
day 67, to allow sufficient time for low redox conditions to become establi hed in the 
microcosms.  This was based on a change in color of the resazurin added to the 
groundwater from pink to clear, indicating that the Eh level decreased below -110 mV (a 
level more conducive to anaerobic dehalogenation).  The dose added corrsponded to 3 
mole percent of the CT initially present (458 µmol/bottle).  A second dose of B12 (the 
same amount as the first) was made on day 554; however, the next sampling point 
indicated no apparent improvement in the average level of CT or CF removal.  It should 
be noted that CT decreased noticeably in one of the three bottles (#3) after the second 
dose of B12, without an increase in CF.  However, the lack of consistent performance 
among the replicates suggests that adding corn syrup + B12 will not be a reliable 
treatment approach for the high concentration plume.   
Bioaugmentation was evaluated with three enrichment cultures.  Table 4.1 
indicates only a modest level of improvement in the average extent of CT removal for the 
treatment with DHM-1 added.  Most of this increase in percent removal was attributable 
to a single bottle; as shown in Figure 4.6 for bottle #3, CT decreased at an accelerating 
rate from 452 µmol/bottle (432 mg/L) on day 245 to 0.1 µmol/bottle (0.1 mg/L) on day 
570, without a commensurate increase in CF.  A second addition of B12 appeared to yield 
a modest decrease in CF, although additional incubation time would have been needed to 
determine if this impact was sustainable.  Regardless, the lack of consistent results for CT 
and CF among the replicates casts doubt on the effectiveness of this treatment strategy for 
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the high concentration plume.  Results for the other two bottles are provided in Appendix 
E.   
Bioaugmentation with SDC-9 was also ineffective.  As shown in Table 4.1, the 
average percent removal of halomethanes from this treatment was not ignificantly 
different from the autoclaved controls or unamended treatment (Student’s t-test, α=0.05).  
As indicated in Figure 4.7, lactate was used as the electron donorfor this treatment, and 
B12 was added at approximately the same time as the addition of SDC-9.  Results for the 
bioaugmentation treatment employing the SRB culture were similar, with no significant 
increase in CT or CF removal in comparison to the autoclaved and unamended controls 
(Table 4.1; Student’s t-test, α=0.05).  Lactate was used as the electron donor for this 
treatment, as indicated in Figure 4.8.   
In contrast to the other treatments, addition of ZVI (0.2 g/bottle) resulted in 
complete removal of CT and nearly complete removal of CF (Table 4.1). Representative 
results for one of the microcosms (bottle #1) are shown in Figure 4.9; results for the other 
two bottles are shown in Appendix E.  CT transformation started immediately after the 
addition of ZVI and decreased from 469 µmol/bottle (448 mg/L) to 124 µmol/bottle (118 
mg/L) on day 2, followed by a slower rate of removal until CT was below detection by 
day 46. There was a corresponding increase in CF, from 136 µmol/bottle (258 mg/L) on 
day 0 to 310 µmol/bottle (585 mg/L) on day 2. Then transformation of CF started, 
decreasing to 9.1 µmol/bottle (17 mg/L) on day 59, with relatively little further decrease 
thereafter. By day 59, 54% of the initial CT and CF had been converted to DCM (on a 
molar basis).  Over a similar time interval, there was a notable increase in another 
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compound, presumptively identified (based on coelution with authentic material) as 1,2-
DCA.  In addition, at least ten other volatile compounds appeared in the chromatograms 
following the addition of ZVI (examples are shown in Appendix F); identifica ion of 
these peaks will require further evaluation.    
Although most of the CF was removed within two months of adding the ZVI, a 
significant amount persisted (17 mg/L).  The first attempt to further decrease the CF was 
made by adding lactate on day 7, followed by addition of B12 (14.1 µmol, to achieve a 
3% molar ratio to the initial CT amount per bottle) and bioaugmentatio  with SDC-9 on 
day 66; this did not yield an appreciable decrease in CF.  The second attempt was made 
on day 270 by adding DHM-1 and a second dose of B12 (0.15 µmol/bottle, based on a 3% 
molar ratio to the remaining CF); however, no further decrease in CF concentration was 
observed.  
To address the high level of DCM that accumulated, the microcosms were 
bioaugmented on day 214 with the DCM enrichment culture, which uses DCM as its sole 
carbon and energy source. And after a lag period of 94 days, transformation of DCM 
started and the level decreased from 304 µmol/bottle (446 mg/L) to 30 µmol/bottle (45 
mg/L) on day 474, but further decreases did not occur. On day 531, another dose of DCM 
culture was added but this did not revive the prior DCM biodegradation activity; it 
remains unclear why the significant level of DCM biodegradation did not continue until 
the compound was completely removed.   
To address the accumulation of the presumptively identified 1,2-DCA, the 
microcosms were bioaugmented on day 251 with a 1,2-DCA respiring culture, along with 
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lactate, which the culture uses as its electron donor.  However, there was no subsequent 
decrease in 1,2-DCA.  The persistence of the CF may have negatively impacted the 
activity of this enrichment culture, which is dominated by Dehalococcoides.    
The average performance of each treatment with respect to CT, CF and DCM is 
summarized in Figure 4.10.  As previously described, the treatment with ZVI was the 
most effective with respect to CT and CF but it resulted in a large increase in DCM.  This 
was partially addressed by bioaugmenting the ZVI bottles with a DCM-degrading 
anaerobic enrichment culture, although complete removal of the DCM was not achieved.  
Among the biotic-only treatments, bioaugmentation with DHM-1 showed the most 
promise, although this was largely due to activity in a single bottle, while the other two 
showed comparatively little activity.  Taken together, these r ults suggest that addition 
of ZVI may be a workable strategy for the highest concentration area of the contaminant 
plume, presuming that the daughter products formed (DCM and a number of other, as yet 
undefined compounds) can be removed as they migrate downgradient.  Further tes ing 
would be needed to evaluate this.   
4.1.2 Medium Concentration Plume (CT ≈ 70 mg/L, CF ≈ 24 mg/L) 
Results for the AC treatment are shown in Figure 4.11.  Percent decreases are 
summarized in Table 4.1. Over an incubation period of 609 days, losses in the autoclaved 
controls for the C1 compounds (CT, CF, DCM and CS2) ranged from 14 to 23%. The loss 
for toluene was 43% and ethylbenzene was not present in most of the treatments for the 
medium concentration. Overall, these results are consistent with those fr m the 
autoclaved controls for the high concentration plume; abiotic losses were generally 
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insignificant (Student’s t-test, α=0.05) in comparison to the biotic and ZVI treatments 
(described below).   
The unamended treatment (Figure 4.12) behaved similarly to the AC bottles 
(Figure 4.11); decreases in CT, CF, DCM, CS2, and toluene were somewhat higher than 
for the AC treatment, but with overlapping standard deviations (Table 4.1).  This 
indicated that there was no significant biotic activity in the unamended treatment 
(Student’s t-test, α=0.05), which is consistent with the lack of activity observed in the 
field. 
Biostimulation with corn syrup alone resulted in a nearly 96% decrease in CT 
(Table 4.1) over an incubation period of 609 days.  As shown in Figure 4.13, CT 
decreased from 71 µmol/bottle (68 mg/L) to 3 µmol/bottle (3 mg/L); corn syrup was 
added five times.  The decrease in CT was accompanied by a 25 µmol/bottle increase in 
CF (from 12 µmol/bottle (23 mg/L) to 37 µmol/bottle (70 mg/L)).  There was no 
significant change in DCM, CS2, or toluene in comparison to the unamended control 
treatment (Student’s t-test, α=0.05).  These results are consistent with expectations that 
addition of electron donor alone may stimulate reductive dechlorination of CT, 
accompanied by a significant (but not stoichiometric) increase in CF. 
Biostimulation with corn syrup plus B12 achieved complete transformation of CT 
and nearly complete removal of CF (Table 4.1).  The performance of a representative 
microcosm (bottle #2) for this treatment is shown in Figure 4.14; results for the other two 
bottles are provided in Appendix E.  In this microcosm, B12 was added on days 66 and 
198. After the first dose of B12 and second dose of corn syrup, biotransformation of CT 
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started approximately seven days later, decreasing from 62 µmol/bottle (60 mg/L) to 
0.4 µmol/bottle (0.4 mg/L) by day 216; by day 392, CT decreased below its MCL of  
0.005 mg/L.  There was no increase in CF as CT was biotransformed. Instead, around day 
306, CF decreased from 12 µmol/bottle (23 mg/L) to below its MCL of 0.080 mg/L by 
day 392.  These results clearly established that adding B12 resulted in complete 
biodegradation of CT and CF in the medium concentration plume, with MCLs reached 
within approximately 400 days.  No significant formation or decrease in DCM, CM, CS2, 
or toluene was observed in comparison to the unamended controls (Student’s t-t s , 
α=0.05).   
Biostimulation with corn syrup plus B12 combined with DHM-1 bioaugmentation 
also resulted in complete removal of CT and CF (Table 4.1).  However, as shown for a 
representative microcosm (bottle #2; results for the other two bottles are provided in 
Appendix E), the rate of CT and CF transformation was faster than with corn syrup plus 
B12 addition alone (Figure 4.15).  Corn syrup and B12 were added at the same times and 
amounts as for the corn syrup plus B12 treatment; DHM-1 was added on days 66 and 243. 
CT decreased from 61 µmol/bottle (59 mg/L) to 0.6 µmol/bottle (0.6 mg/L) on day 210 
and dropped below the MCL on day 342, approximately 50 days earlier than 
biostimulation with corn syrup plus B12. Close to day 306, CF transformation started and 
dropped below the MCL before day 428.  In an attempt to remove the DCM, the DCM 
enrichment culture was added on day 520.  DCM decreased from 12 µmol/bottle (17 
mg/L) to 9 µmol/bottle (13 mg/L) by day 599; additional incubation wuld be required to 
determine if this trend was sustainable.  No significant formation or decrease in CM, CS2, 
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or toluene was observed in comparison to the unamended controls (Student’s t-t s , 
α=0.05).  It is notable that in this treatment, methane began to accumulate after day 520.  
This indirectly reflects the removal of CT and CF, which are potent inhibitors of 
methanogenesis.   
Biostimulation with lactate plus B12 combined with SDC-9 bioaugmentation 
resulted in complete removal of CT and 88% removal of CF (Table 4.1).  Two of the 
three microcosms achieved complete transformation of CF over an incubation period of 
599 days.  In the third microcosm, only 64% removal of CF was observed at the end of 
the incubation period; a second dose of B12 was added on day 554, yet 45 days later the 
CF still persisted.  In the representative microcosm (Figure 4.16; results for the other two 
bottles are provided in Appendix E), B12 was added on day 66 and SDC-9 was added on 
days 66 and 347; the lack of a second addition of B12 (once the CT was consumed) was 
an oversight.  This was fortuitous, however, since the results showed that complete CF 
removal was possible without the second B12 addition in two of the three microcosms. In 
the representative microcosm (Figure 4.16), CT decreased from 75 µmol/bottle (71 mg/L) 
to 0.24 µmol/bottle (0.23 mg/L) on day 247 and dropped below the MCL on day 528. 
Close to day 247, CF transformation started but the rate was relatively slow. After the 
second dose of SDC-9, the CF transformation rate increased substantially and 
transformation below the MCL was complete by day 528.  In an attempt to remove DCM, 
the DCM enrichment culture was added on day 528; however, there was no apparent 
response through day 599, when monitoring ended.  No significant formatin or decrease 
 31
in CM, CS2, or toluene was observed in comparison to the unamended controls (Student’s 
t-test, α=0.05). 
Biostimulation with lactate plus B12 combined with bioaugmentation using the 
SRB enrichment culture resulted in 94% removal of CT but no removal of CF (Table 
4.1).  Over an incubation time of 599 days, two of the three microcosms completed 
transformation of CT to below its MCL; in the third bottle, only 83% of the CT was 
transformed.  Figure 4.17 shows the results for bottle #1; results for the other two bottles 
are provided in Appendix E.  B12 and SRB culture were added on day 170.  CT decreased 
to below its MCL by day 486, which was a notably slower rate than in the other biotic 
treatments that also received B12.  CF did not increase during this interval, nor did it 
decrease significantly during the remainder of the incubation period.  A second dose of 
bioaugmentation culture was not made, since the SRB culture was not maintained over 
this extended interval.  While it is possible that a second dose of SRB culture may have 
resulted in CF removal, the slower rate of activity on CT suggests the SRB culture is not 
an effective alternative to DHM-1 or SDC-9.   
Addition of ZVI (0.2 g/bottle) resulted in complete removal of CT and CF (Table 
4.1).  Representative results for one of the microcosms (bottle #2) are shown in Figure 
4.18; results for the other two bottles are provided in Appendix E.  The patt rns observed 
were similar to those for the high concentration plume (Figure 4.9).  CT transformation 
started immediately, decreasing from 70 µmol/bottle (67 mg/L) to 1.2 µmol/bottle (1.2 
mg/L) on day 2 and below the MCL by day 33. CF initially increased from 13 
µmol/bottle (24 mg/L) to 36 µmol/bottle (69 mg/L), then decreased to below the MCL by 
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day 66. While CT and CF were undergoing transformation, DCM increased from 14 
µmol/bottle (20 mg/L) to a peak of 76 µmol/bottle (111 mg/L). The daughter product 
presumptively identified as 1,2-DCA appeared in this treatment, as it did in the high 
concentration ZVI treatment (Figure 4.9).  Other daughter products that did not appear in 
any of the other treatments also appeared in the chromatograms for the medium 
concentration ZVI microcosms, similar to the high concentration ZVI treatment  
(Appendix F).  This included a compound that eluted at the same time as ethylbenzene.  It 
is unlikely that ethylbenzene was formed as a consequence of ZVI addition; the identity 
of this compound therefore remains uncertain.   
One unusual feature of the medium concentration ZVI results was the 
unexpectedly abrupt decrease in CF that occurred between days 63 to 13  after the CF 
had seemingly reached a plateau at approximately 6-10 µmol/bottle.  For bottle #2 
(Figure 4.18), the decrease occurred between days 63 and day 66, when the CF decreased 
to below detection.  This was before the addition of SDC-9 and B12 on day 66 (to all three 
bottles), so bioaugmentation was not an explanation for the decrease in this bottle.  In the 
other two bottles, however, the decrease occurred after bioaugmentation and addition of 
B12 (between days 163 and 168 in bottle #1 and days 66 and 79 in bottle #3), so this may 
have facilitated CF removal.  Another possible explanation is an analytical artifact; CF 
eluted very close in time to a considerably larger peak that was presumptively identified 
as 1,2-DCA.  Over time, the difference in retention times betwe n these peaks decreased 
slightly, such that the CF peak merged into the larger peak and the integrator started 
reporting the sum of the two peaks, not CF.  The large number and magnitude of the 
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daughter products formed in the medium concentration ZVI bottles made quantification 
of CF more challenging.       
To address the increase in DCM from ZVI facilitated reductive dechlorination of 
CT and CF, a dose of the DCM enrichment culture was added on day 161.  DCM
decreased immediately thereafter from 65 µmol/bottle (95 mg/L) to 39 µmol/bottle (57 
mg/L) on day 174; this level was comparable to the final concentration of DCM in the 
high concentration ZVI treatment (Figure 4.9).  Additional doses of the DCM culture 
were added on days 194, 276 and 528, to no avail.  It is unclear what inhibited the DCM 
culture; it was not the DCM concentration, since the culture was acclimated to levels of 
approximately 500 mg/L.  
To address the accumulation of the presumptively identified 1,2-DCA, the 
microcosms were bioaugmented on day 251 with a 1,2-DCA respiring culture, along with 
lactate, which the culture uses as its electron donor.  However, there was no subsequent 
decrease in 1,2-DCA.  By this time, CT and CF were sufficiently low that they could not 
have inhibited the activity of the Dehalococcoides that are responsible for 
dihaloelimination of 1,2-DCA to ethene.  The lack of activity may indicate that the 
compound in question was not actually 1,2-DCA, or that some other compound was 
inhibiting the Dehalococcoides.    
The average performance of each treatment with respect to CT, CF and DCM is 
summarized in Figure 4.19.  All of the biostimulated and bioaugmented treatments 
achieved complete or nearly complete removal of CT.  The treatment with ZVI added 
was by far the fastest.  The treatment with corn syrup + B12 was only marginally slower 
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than the DHM-1 bioaugmented treatment, while the SDC-9 bioaugmented treatment 
lagged behind.  With respect to CF, the ZVI + SDC-9 bioaugmented treatment was 
fastest, followed by the corn syrup + B12 and DHM-1 bioaugmented treatments.  The 
SDC-9 bioaugmented treatment was slower, but that was likely a consequence of not 
adding the second dose of B12.  No significant removal of CF occurred in the unamended 
control or the SRB bioaugmented treatment; this may have also been a co sequence of 
not adding a second dose of B12.  With respect to DCM, a significant increase occurred in 
the ZVI treatment that was only partially offset by addition of the DCM enrichment 
culture.  The DCM culture was largely ineffective in the other tr atments; it is unclear 
what was inhibiting the culture.   
4.1.3 Low concentration plume (CT ≈ 5 mg/L, CF ≈ 1~2 mg/L) 
Results for the AC treatment are shown in Figure 4.20.  Percent decreas s are 
summarized in Table 4.1. Over an incubation period of 583 days, decreases in CT and CF 
averaged 31% and 17%, respectively.  DCM and CM remained below 0.050 µmol/bottle 
throughout the incubation period.  CS2 fluctuated over time (reflecting the lower 
precision for measuring CS2 with a flame ionization detector), although the final reading 
was similar to the initial value. Toluene and ethylbenzene were not present in the low 
concentration plume.  
In the unamended treatment (Figure 4.21), the decreases in CT and CF were not 
significantly different from the autoclaved controls (Table 4.1; Student’s t-test, α=0.05)  
This is consistent with field observations, i.e., a lack of any appreciabl  transformation 
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CT or CF in the low concentration plume.    There was also no appreciabl  change in 
CS2.   
Biostimulation with corn syrup resulted in complete removal of CT (Figure 4.22).  
Commensurate with the decrease in CT was an increase in CF from 0.69 µmol/bottle (1.3 
mg/L) to 1.59 µmol/bottle (3 mg/L) on day 248.  CF levels decreased to 1.04 µmol/bottle 
(2 mg/L) at the end of the incubation period.  The decrease in CT was also accompanied 
by a noticeable increase in CS2, which then declined over time to approximately the same 
level as at the start.   
Biostimulation with corn syrup plus B12 resulted in complete removal of CT and 
CF, without pH adjustment of the groundwater (Figure 4.23; Table 4.1).  While CT was 
being consumed, CF increased but then declined to below its MCL by day 522.  CS2 also 
increased as CT was consumed and subsequently decreased to approximately the same 
level as at the start of the incubation.  The increases in CF and CS2 were likely a 
consequence of not adding B12 until after the decline in CT started; had the B12 been 
added earlier, it is less likely that there would have been an increase in CF or CS2.       
pH adjustment of the groundwater to circumneutral followed by biostimulation 
with corn syrup plus B12 also resulted in complete removal of CT and CF (Figure 4.24; 
Table 4.1).  The maximum rates of CT and CF removal were faster than for the treatment 
without pH adjustment.  Otherwise, the patterns were similar; i.e., the decrease in CT was 
accompanied by a rise in CF and CS2, both of which decreased once the CT was 
consumed.  As with the corn syrup plus B12 treatment, B12 was not added until after the 
decrease in CT started, which likely allowed for a transient increase in CF.  It should be 
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noted that corn syrup additions were made later with this treatment than the others; corn 
syrup was not added until the groundwater pH was stabilized.  It is also notable that 
methane began to accumulate at the end of the incubation period, once CT and F were 
below their MCL levels.   
The average performance of each treatment with respect to CT, CF and DCM is 
summarized in Figure 4.25.  The three biostimulated treatments achieved complete 
removal of CT; the treatments with B12 added reached the MCL at a faster rate.  Only the 
two treatments with B12 added achieved complete biodegradation of CF, with the pH 
adjusted treatment reaching the MCL several months sooner.  None of th treatments 
achieved complete removal of DCM, although the initial levels were low (0.020-0.030 
µmol/bottle or 0.030-0.046 mg/L).  DCM ended at close to the initial levels for most of 
the treatments, with the exception of biostimulation with corn syrup pls B12, in which 
the level approximately tripled.   
4.1.4 Results Summary for Site A 
The overall results are summarized in Table 4.2.  For the high concentration 
plume, the only treatment that was effective for CT was addition of ZVI followed by 
bioaugmentation.  CT was completely removed by the ZVI alone.  Mostof the CF was 
also removed, but then the activity stalled.  DCM levels rose considerably during reaction 
of the CT and CF with ZVI; an attempt to remove the DCM via bioaugmentation with a 
DCM-degrading enrichment culture was only partially effective; for reasons that are not 
yet clear, biodegradation of DCM stalled when the concentration reached 45 mg/L.  
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Nevertheless, since the plume will migrate into the lower concentration zones 
downgradient, there would still be ample opportunity to remove the remaining DCM.   
For the medium concentration plume, three of the treatments that included 
addition of B12 (M-BB12, M-BIOA and M-BIOB) were effective in completely removing 
CT and one was effective in completely removing CF (M-BIOA).  Bioaugmentation did 
not improve the rate of CT or CF biodegradation, and therefore, does not appear to be 
warranted.  For DCM, addition of a DCM enrichment culture showed some promise near 
the end of the incubation period (M-BIOA); additional monitoring would be ne ded to 
determine if complete removal is feasible.  In the other biostimulation treatments, DCM 
remained relatively unchanged from its initial concentration.  Addition of ZVI was also 
effective for removing CT and CF in the medium concentration plume.  However, this 
yielded a significant increase in the DCM concentration that was only partially removed 
by addition of the DCM enrichment culture.  Since biostimulation thatincludes B12 
avoids this increase (as well as an increase in other products that have not yet been 
identified), this approach is preferable to ZVI addition.  However, costnsiderations 
(primarily for the B12) also need to be taken into account.   
For the low concentration plume, biostimulation that included addition of B12 was 
effective in completely removing CT and CF.  Increasing the pH of the groundwater 
improved the rate of removal, although the cost of doing so would need to be weighed 
against the improvement in rate.  The concentration of DCM increased in the treatment 
without pH adjustment, which is another factor that would need to be taken into account.  
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No attempt was made to evaluate bioaugmentation of the low concentration plume 
microcosms to remove the DCM.   
4.2 Site B (CT ≈ 20 mg/L, CF ≈ 80 mg/L) 
Results for the AC treatment are shown in Figures 4.26; percent decreas s are 
summarized in Table 4.3.  Over an incubation period of 716 days, the losses in the 
autoclaved controls for CF and CT were 21% and 30%, respectively.  The initial amount 
of DCM present was considerably lower and actually increased slightly over time (from 1 
µmol/bottle (2 mg/L) to 3 µmol/bottle (4 mg/L)).  CS2 was not detected.  The percentage 
decrease in 1,2-DCA was similar to CT, while the decrease was highest for 1,1,2-TCA 
(44%).  Overall, the magnitude of losses from the AC treatment was considered 
acceptable, given the long incubation period.   
Compared to the AC treatment, the unamended treatment (Figure 4.27) had a
similar percent loss for CT (33%; Table 4.3) but significantly higher percent losses for 
the other compounds (Student’s t-test, α=0.05).  These results indicate that there was 
biotic activity in the unamended treatment, although the rate was insufficient to achieve 
complete removal over the period of time the microcosms were monitored (~2 years).   
The vertical rise in CT, CF, and DCM in all of the treatments on day 677 was a 
consequence of adding 6-8 mL of groundwater (which contained the chlorinated 
compounds) back to the microcosms.  This volume had been removed over time due to 
repeated sampling to measure sulfate.  The reason for closely monitoring sulfate is 
described below.  To restore the ratio of headspace to liquid volume (on which the GC 
response factors are based), it was necessary to add groundwater back to the microcosms. 
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The impacts of groundwater withdrawals on the GC response factors of the contaminants 
for each treatment are summarized in Appendix G; for CT, the impact was less than 1%, 
while for CF, the maximum impact was 12.3%.  In the case of the unamended treatment, 
the biodegradation rates for CT, CF, and DCM biodegradation did not change 
appreciably after adding the groundwater.   
Biostimulation with corn syrup resulted in nearly complete removal of CT (Figure 
4.28; Table 4.3) and a higher percent removal of CF and 1,1,2-TCA compared to the 
unamended treatment.  When groundwater was added back to the microcosms n day 
677, the subsequent rate of biodegradation activity was no faster than the previous rate.  
These results indicate that biostimulation improved the level of biotic activity over the 
unamended treatment, but may not be sufficient to achieve complete treatment in a timely 
manner.   
Unlike Site A, addition of B12 along with corn syrup did not appreciably improve 
the rate or extent of biodegradation in comparison to addition of only crn syrup (Table 
4.3).  B12 was added twice (Figure 4.29), with no apparent benefit.  A potential reason for 
the lack of response may be the inability to maintain an adequate level of sulfide; the 
issue of sulfate reduction is discussed below.  When groundwater was added back to the 
microcosms on day 677, the rates of biodegradation were similar to previous activity.   
Bioaugmentation with DHM-1 achieved a modest improvement in biodegradation 
activity (Figure 4.30).  CT removal was complete (i.e., below the MCL) and the percent 
removal of CF was higher than in the other treatments, although it was still not complete 
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by the end of the incubation period (Table 4.3).  It is not clear if the magnitude of 
improvement would justify the added expense for bioaugmentation.   
The lack of improvement in the biodegradation rate for CT and CF from adding 
B12 was unexpected.  In numerous previous studies and from the results for Site A, 
adding B12 significantly improved the rate and extent of CT and CF biodegradation nd 
resulted in significantly lower accumulation of chlorinated daughter products.  It was 
hypothesized that a lack of sulfide in the groundwater may be a factor.  The activity of 
DHM-1 and B12 is strongly dependent on sulfide being present in the medium (40), with 
the role of sulfide likely related to providing sufficiently low redox levels to drive 
continually redox cycling of B12 (4).  The initial concentration of sulfate in the Site B 
groundwater was only 0.11 mM.  Beginning on day 394, 1.5 mM of sulfate (75 µL of a 
1M solution of Na2SO4) was added to the bioaugmentation (BIO) treatment; the same 
dose was provided to the biostimulation (BST) and B12 treatments beginning on day 465 
(Figure 4.31).  Sulfate concentrations were measured after 20-60 days of incubation and 
when the concentration decreased by at least 0.5 mM, more sulfate was added so that the 
concentration was returned to approximately 1.5 mM.  The bioaugmented treatment 
consumed the most amount of sulfate (Figure 4.31b); nevertheless, the impact on the rate 
of CT and CF removal was small.  Sulfide was not measured, so it i  not known if the 
dissolved level of sulfide increased as a consequence of sulfate reduction.   
Figure 4.32 and Table 4.4 provide summaries of the results for Site B in terms of 
CT, CF and DCM.  The biotic amended treatments achieved CT removal to similar 
extents and at similar rates.  CF was removed in all of the biotic treatments to similar 
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extents and at similar rates; this result for the unamended microcosms was unexpected, 
but confirmed the presence of CF biodegrading conditions in situ.  For DCM, there was 
no significant difference in percent removal between the unamended treatment (i.e., 
CON) and the other live treatments (i.e., BST and BB12).  Furthermor , the initial 
concentration of DCM was considerably lower than for CT and CF.  
4.3 Effect of B12 to CF Ratio on the Rate of CF Biodegradation by DHM-1 
The effect of B12 dose on the maximum rate of transformation of 500 mg/L of CF 
by DHM-1 is shown in Figure 4.33; results for the individual bottles used to generate this 
figure are provided in Appendix H.  Reducing the molar ratio of B12 added per mole of 
CF added from 0.03 mol B12 per mol of CF added to 0.01 resulted in a moderate decrease 
in the maximum CF transformation rate, while the rate fell more quickly below 0.01.  
Fitting the data to equation 3.1 resulted in a Vmax of 66±4.6 mg CF/L·d and a B12/Km ratio 
of 0.0050±0.0010 mol B12 per mol CF (± values indicate 95% confidence intervals).  
Assuming a yield of 50-60 mg protein/L from the single dose of corn syrup added (40), 
Vmax can be normalized to approximately 1.2 mg CF/mg protein·d.  
4.4 Effect of pH on the Rate of CF Biodegradation by DHM-1 
Maximum CF biodegradation rates for DHM-1 increased with increasing pH from 
5.0 to 7.7 (Figure 4.34; results for the individual bottles used to generate this figure are 
provided in Appendix I). There appeared to be a plateau in the pH range from 6.4 to 7.3, 
while the rate almost doubled at pH 7.7, reaching 50 mg/L·d. The activity of DHM-1 
diminished substantially below pH 6.0 and ceased at pH of 5.0.  Lag times (i.e., the time 




For Site A, in the vicinity of the source zone (i.e., the high concentration plume), 
bioaugmentation with DHM-1 was the only bioremediation strategy which showed 
partially effective performance on the biotransformation of CT. However, only one out of 
three microcosms completed the transformation of CT. No significa t degradation of CF 
happened in any of the treatments for the high concentration plume except the one 
amended with ZVI. The feasibility of using bioremediation to clean up halogenated 
solvents in the source zone depends in part on the ability of microbes t grow in the 
presence of contaminant concentrations that approach their aqueous solubility. It has been 
proved that DHM-1 has the ability to grow and biodegrade CF at leas as high as 500 
mg/L (40). Therefore, in this case, it appears that the high concentration of CT is the 
reason for the lack of activity on CF, via competitive reactions with critical enzymes (49) 
and/or cellular membrane damage (41).  The CT concentration in the source zone plume 
(~500 mg/L) is well above half of the aqueous solubility of CT and CT is known to 
inhibit anaerobic bacteria at a concentration as low as 9 mg/L (7). Further work is needed 
to evaluate the effect of high concentrations of CT on bioaugmentation cultures such as 
DHM-1.  
For the medium concentration plume (CT ~70 mg/L, CF ~24 mg/L), the 
biostimulation and bioaugmentation treatments with B12 added proved to be at least 
partially effective at removing CT and CF; the bioaugmentation treatment with DHM-1 
(M-BIOA) accomplished complete removal (i.e., below the MCL levels).  B12 was a 
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crucial factor in enhancing the transformation rate and shifting the pathway away from 
reductive dechlorination towards hydrolytic and substitutive reactions so that CF and 
DCM did not accumulate. These observations are consistent with previous studies that 
demonstrated the benefit of adding catalytic levels of B12 to biodegrade CT and CF (3, 7, 
23-24, 37). In this study, the benefit of bioaugmenting the medium concentratio  
microcosms yielded only a modest improvement in the outcome, while bioaugmentation 
(with a culture that preceded DHM-1) was more effective in an experiment conducted by 
Shan et al. (39). At Site A, the indigenous microbial community has the ability to 
biodegrade CT and CF when provided with corn syrup and B12. When comparing the 
treatments that received corn syrup and B12 (M-BB12 and M-BIOA) versus lactate (M-
BIOB and M-BIOC), it appears that corn syrup was a more effective electron donor for 
this site.  However, since this comparison involved factors in addition to the electron 
donor (i.e., the culture source), this is not an entirely robust conclusion.  From a 
physiological standpoint, the fermentation of corn syrup is likely to support the growth of 
a wider range of anaerobes than lactate, based on a greater variety of organic acids 
produced that would then undergo further acidogenesis (18).  In the exp riment 
conducted by Shan et al. (39), corn syrup was also more effective than o er tested 
electron donors including emulsified vegetable oil and lactate.  Consideri g that 
biodegradation of CT and CF has been found under many different anaerobic conditions 
and the transformation is mediated by nonspecific cometabolic processes (35), it is 
possible that most subsurface ecosystems have a latent capacity for CT and CF 
transformation.  Further research is needed to identify the specific conditions needed to 
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ensure rapid biodegradation of CT and CF degradation without accumulation of lesser 
chlorinated daughter products.  
ZVI was very effective in rapidly transforming CT and CF, primarily to DCM.  
The accumulation of a lesser chlorinated daughter product is consistent with other studies 
that have evaluated ZVI treatment of halomethanes (10, 26). In the case of Site A the 
reaction stopped at DCM (there was no apparent increase in CM or CH4), which is not a 
desirable end product. Another shortcoming with ZVI that was evident with Site A was 
an increase in a substantial number of other volatile reaction products, based on an 
increase in the number of peaks that eluted during GC analysis of headspace samples.  
Further work is needed to identify these compounds and ascertain if they pose a 
toxicological hazard.  In the case of the high concentration plume, it is possible that use 
of ZVI in the source zone would be acceptable, since the daughter products will migrate 
downgradient and conditions for bioremediation may become more favorable.  
Nevertheless, identifying the unknown volatile products is needed to fully evaluate the 
efficacy of ZVI treatment.   
In response to the need to treat the large quantity of DCM produced in the ZVI 
treatments, a DCM enrichment culture capable of biodegrading at leas 500 mg/L of 
DCM was developed in a sediment-free medium.  After bioaugmenting the high and 
medium concentration ZVI treatments, the DCM culture was effective initially but then 
biodegradation abruptly and unexpectedly stopped. The reason why this phenomeno  
happened still needs to be identified. Other microbial consortia and strains capable of 
DCM degradation have only been evaluated under highly controlled and optimum 
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conditions (13, 30), rather than in the “messy” environment of post-ZVI treatment. The 
factors that inhibit these DCM degraders still need to be evaluated. 
For Site B, the addition of corn syrup accelerated the transformati n of CT; 
however, addition of B12 and bioaugmentation failed to accelerate the rate or extent of 
biodegradation. Compared to the unamended control, biostimulation and 
bioaugmentation both failed to enhance the degradation of CF. The reason for this 
unresponsive behavior is thought to be the lack of sulfide, which is needed by DHM-1 for 
transformation of CF (40). In spite of a high rate of sulfate consumption by the DHM-1 
bioaugmented treatment, there was no enhancement of CF biodegradation.  If sulfide had 
been measured, it would have made it possible to determine if sulfide was present or if 
the sulfide demand of the subsurface material exceeded the amount generated.  In this 
study, 12 mM of sulfate was consumed and presumably reduced to sulfide.  Since the 
microcosms contained 20 g of subsurface material, the sulfide dose wa  0.96 mg/g 
subsurface material.  This is well above the dose required to satisfy the sulfide demand 
for subsurface material at a different hazardous waste site, wh re direct addition of 
sulfide was evaluated to reduce hexavalent to trivalent chromium (16). Apparently the 
sulfide demand for the subsurface material at Site B is even higher.      
One of the concerns with using an enrichment culture such as DHM-1 for 
bioaugmentation is its relatively high requirement for B12.  Shan et al. (39-40) used a B12 
molar dose of 3%, i.e., 0.03 mol B12 per mol CF.  Varying the B12 dose in this study 
indicated a half saturation value of 0.5%; i.e., the CF biodegradation rate was one-half its 
maximum at 0.005 mol B12/mol CF.  This same B12 to CT molar ratio also significantly 
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improved the rate of CT degradation in a methanogenic sludge consortium, at a CT 
concentration of 15.4 mg/L (20).  Nevertheless, for halomethane concentrations in the 
hundreds of mg/L, the B12 required by DHM-1 is several orders of magnitude higher than 
what is used to grow Dehalococcoides (25).  Further work is needed to find a lower cost 
alternative to highly purified B12. 
Aquifer pH is a significant concern for bioaugmentation, since many cultures lose 
their effectiveness at pH levels below 6 or above 8.  The highest pH evaluated in this 
study was 7.6, which yielded a significantly higher rate than in the circumneutral pH 
region (i.e., 6.3-7.3; Figure 4.34).  CF biodegradation rates decreased significantly below 
6.0 and activity essentially ceased at pH 5.0.  This is similar to the behavior of many 
Dehalococcoides enrichment cultures used for bioaugmentation of chlorinated ethene 
plumes.  The difficulties associated with adjusting aquifer pH include non-homogenous 
distribution of the buffering agent and the potential for clogging due to precipitation 
when pH is increased.  The need to control aquifer pH is a factor that must be considered 





Based on the results of this study, the following conclusions were reached for 
bioremediation of Site A:   
1. Addition of ZVI followed by bioaugmentation was the most promising approach 
evaluated for removal of CT, and CF from the high concentration plume.  This
strategy achieved complete removal of CT, nearly complete removal of CF and 
partial removal of the DCM that accumulated during reaction of the CT and CF 
with ZVI.  There is still a need to determine if the other volatile compounds 
formed during reaction with ZVI pose a concern for downgradient remediation. 
2. Biostimulation with corn syrup plus B12 was effective for removal of CT and 
almost all of the CF from the medium concentration plume.  Bioaugmentation did 
not improve the rate of transformation; however, addition of DHM-1 ensured 
complete removal of CF.  SDC-9 and a SRB enrichment culture developed for use 
in this study were less effective for removal of CT and CF in the medium 
concentration microcosms.   
3. An anaerobic enrichment culture that grows on DCM as its sole carbon and 
energy source was successfully developed.  It was acclimated to consume up to 
500 mg/L of DCM.  Use of the culture for bioaugmentation to remove DCM was 
partially effective; additional work is needed to optimize the use of the culture.  
Although ZVI plus bioaugmentation removed CT and CF at a faster rat, the 
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accumulation of DCM was a concern that was only partially addressed by 
bioaugmentation with the DCM enrichment culture. 
4. For the low concentration plume, biostimulation with corn syrup plus B12 was the 
most promising approach evaluated for removal of CT and CF.  Adjusting the pH 
of the groundwater improved the rate of transformation, although this must be 
weighed against the cost of in situ pH adjustment.  No attempt was made to 
remove the low level of DCM present in the low concentration plume. 
 
Based on the results of this study, the following conclusions were reached for 
bioremediation of Site B:   
1. Biostimulation with corn syrup was effective in removing CT; however, addition 
of B12 and bioaugmentation did not appreciably enhance the rate or extent of CT 
biodegradation.   
2. Biostimulation and bioaugmentation did not improve the rate of CF removal over 
the unamended treatment.  The rate of CF removal was slow and consistent in the 
biotic treatments.    
3. None of the amendments were effective in removing DCM, although it was 
present at a lower concentration than CT and CF.   
4. Attempts to stimulate the effectiveness of B12 and bioaugmentation by generating 
sulfide via sulfate reduction were not effective.  Although 12 mM of sulfate was 
consumed in the treatment bioaugmented with DHM-1, there was no 
enhancement in the rate or extent of CT or CF biodegradation.  This suggests that 
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the subsurface material has a considerable sulfide demand that needs to be 
satisfied before the effectiveness of B12 and DHM-1 can be realized.    
 
Based on the results of this study, the following conclusions werereached with 
respect to further characterization of the DHM-1 bioaugmentation culture:   
1. Maximum CF biodegradation rates for DHM-1 increased with increasing pH from 
5.0 to 7.7. Its activity is severely inhibited by pH levels below 6.0. At pH 5.0, it 
lost its ability to biotransform CF. Between pH 6.4 and 7.3, the rate of CF 
biodegradation by DHM-1 is somewhat stable; however, it increases rapidly 
between pH 7.3 and 7.7. Given the inhibitory effect of pH levels below 6.0, the 
pH of the groundwater should be adjusted within the neutral range for succes ful 
bioaugmentation to occur.  The sensitivity of DHM-1 to low pH values mu t be 
considered for application in aquifers that have pH levels below 6.   
2. Maximum CF biodegradation rates for DHM-1 increased with increasing vitamin 
B12 dose. The relationship between the B12 to CF ratio and the rate of CF 
biodegradation can be described by a modification of the Michaelis-M nten 
kinetics model. A Vmax of 66±4.6 mg CF/L·d and a B12/Km ratio of 0.0050±0.0010 
mol B12 per mol CF were obtained from fitting experimental results to his model. 
This information can help in the selection of a cost-effective dosefor B12 when it 






Table 3.1  Media used for enrichment culturesa. 
 
a All values in mg/L. 
 
 Type of Media 
Compound DHM-1 Culture SRB Culture DCM Culture 
K2HPO4 410 410 525 
NaHCO3 4000 4000 800 
NH4Cl 300 300 535 
MgCl2·6H2O 400 400 - 
MgSO4·7H2O - - 125 
CaCl2·2H2O 150 150 47 
ZnSO4·7H2O - - 0.42 
MnCl2·4H2O 0.1 0.1 2 
CoCl2·6H2O 0.19 0.19 3 
Na2MoO4·2H2O 0.036 0.036 - 
KCl 300 300 - 
Na2S·9H2O 120 120 240 
FeCl2·H2O - - 162.6 
FeCl2·4H2O 1.5 1.5 - 
ZnCl2 0.07 0.07 - 
H3BO4 0.006 0.006 0.6 
NiCl2·6H2O 0.024 0.024 1.5 
CuCl2·2H2O 0.002 0.002 0.2 
Na2SeO3 - - 0.04 
Na2SeO3·5H2O 0.005 0.005 - 
Al 2(SO4)3·16H2O - - 0.2 
Resazurin 1 1 1 
Yeast Extract 50 50 50 
Na2SO4 - 5268.2 - 
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Bioaugmentation Culture 




ID Treatment Description 
SM 
Type GW Type CT CS Lac B12 A B C D E ZVI 
High H-AC Autoclaved control PZ-95 PZ-95-2 yes - - - - - - - - - 
High H-WC Water control - - yes - - - - - - - - - 
High H-Con Unamended control PZ-95 PZ-95-2 yes - - - - - - - - - 
High H-BST Biostimulation PZ-95 PZ-95-2 yes yes - - - - - - - - 
High H-BB12 Biostimulation + B12 PZ-95 PZ-95-2 yes yes - yes - - - - - - 
High H-BIOA Bioaugmentation A PZ-95 PZ-95-2 yes yes - yes yes - - - - - 
High H-BIOB Bioaugmentation B PZ-95 PZ-95-2 yes - yes yes - yes - - - - 
High H-BIOC Bioaugmentation C PZ-95 PZ-95-2 yes - yes yes - - yes - - - 
High H-ZBIO ZVI + bioaugmentation PZ-95 PZ-95-2 yes yes yes yes yes - - yes yes yes 
               
Medium M-AC Autoclaved control TP-1 TP-4 yes - - - - - - - - - 
Medium M-Con Unamended control TP-1 TP-4 yes - - - - - - - - - 
Medium M-BST Biostimulation TP-1 TP-4 yes yes - - - - - - - - 
Medium M-BB12 Biostimulation + B12 TP-1 TP-4 yes yes - yes - - - - - - 
Medium M-BIOA Bioaugmentation A TP-1 TP-4 yes yes - yes yes - - - yes - 
Medium M-BIOB Bioaugmentation B TP-1 TP-4 yes - yes yes - yes - - yes - 
Medium M-BIOC Bioaugmentation C TP-1 TP-4 yes - yes yes - - yes - - - 
Medium M-ZBIO ZVI + bioaugmentation TP-1 TP-4 yes - yes yes -yes - yes yes yes 
               
Low L-AC Autoclaved control PZ-12 PZ-12 yes - - - - - - - - - 
Low L-Con Unamended control PZ-12 PZ-12 yes - - - - - - - - - 
Low L-BST Biostimulation PZ-12 PZ-12 yes yes - - - - - - - - 
Low L-BB12 Biostimulation + B12 PZ-12 PZ-12 yes yes - yes - - - - - - 
Low L-ABST Biostim + B12 + pH PZ-12 PZ-12 yes yes - yes - - - - - - 
a  SM = subsurface material; GW = groundwater; CS = corn syrup; Bioaugmentation culture A = DHM-1; B= SDC-9; C = SRB 
enrichment culture; D = 1,2-DCA enrichment culture; E = DCM enrichment culture.   The quantities added to each bottle are specified 
in the text.  
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Table 3.3  Summary of the CT and CF concentrations for Site A 
(mg/L). 
Contaminant High Medium Low 
CT 400 50 5 
CF 340 20 1 
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Description CS B12 DHM-1 
AC Autoclaved control - - - 
Con Unamended control - - - 
BST Biostimulation yes - - 
BB12 Biostimulation + B12 yes yes - 
BIO Bioaugmentation yes yes yes 
a  CS = corn syrup.
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Table 4.1  Summary of percent removals of CT, CF, DCM, CS2, toluene and ethylbenzene




Time (d) CT CF DCM CS2 Toluene Ethylbenzene 
H-AC 577 28.9±2.2 28.2±2.8 25.9±4.5 23.5±2.1 52.0±2.7 59.3±3.5 
H-WC 412 28.1±0.9 35.8±2.8 20.9±2.6 - - - 
H-Con 577 25.2±3.2 28.7±1.6 24.0±1.8 25.2±0.9 50.6±1.2 60.2±3.2 
H-BST 577 24.0±6.7 27.8±2.3 21.7±1.4 16.7±7.7 53.6±2.9 64.1±1.9 
H-BB12 576 32.4±10.3 30.4±3.8 27.4±1.5 26.8±4.9 53.5±3.3 56.0±12.3 
H-BIOA 570 51.6±42.0 31.9±2.2 28.2±2.1 34.9±10.9 55.0±5.4 62.4±6.3 
H-BIOB 576 24.4±2.8 28.0±1.5 23.2±1.3 22.3±1.9 44.0±12.2 57.4±2.7 
H-BIOC 570 20.7±0.9 28.3±1.4 24.9±1.2 23.1±1.1 47.7±1.4 57.0±5.8 
H-ZBIO 570 100.0±0.0 96.6±0.7 +b 42.1±14.7 43.8±22.1 68.6±4.9 
        
M-AC 609 22.7±1.6 14.2±1.6 15.2±1.9 20.9±1.1 43.2±3.5 - 
M-Con 609 32.5±8.0 19.5±4.2 33.3±13.0 32.4±17.1 44.6±3.5 - 
M-BST 609 95.8±4.9 + 27.0±2.4 26.5±1.1 42.8±0.4 - 
M-BB12 609 100.0±0.0 98.1±3.3 21.0±1.6 24.3±2.8 46.6±3.7 - 
M-BIOA 599 100.0±0.0 100.0±0.0 37.3±3.9 19.8±1.4 46.2±6.5 - 
M-BIOB 599 100.0±0.0 88.1±20.6 27.8±10.3 20.8±2.1 46.4±7.4 - 
M-BIOC 599 94.2±10.0 6.0±14.4 17.1±0.7 18.4±1.6 43.9±1.9 - 
M-ZBIO 609 100.0±0.0 100.0±0.0 + 66.7±4.2 - - 
        
L-AC 583 31.4±3.3 17.0±14.6 + + - - 
L-Con 583 32.4±2.3 26.5±9.6 63.7±28.9 41.1±13.2 - - 
L-BST 583 100.0±0.0 + + + - - 
L-BB12 583 100.0±0.0 100.0±0.0 + + - - 
L-ABST 583 100.0±0.0 100.0±0.0 + 11.2±17.0 - - 
a Average of triplicates ± one standard deviation.   b + indicates an increase occurred relative to the initial concentratio .     
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Table 4.2  Summary of treatment effectiveness of removing CT, CF and DCMa for Site A .  
Plume Treatment CT CF DCM 
High Concentration H-Con not effective not effective not effective 
 H-BST not effective not effective not effective 
 H-BB12 not effective not effective not effective 
 H-BIOA partially effective not effective not effective 
 H-BIOB not effective not effective not effective 
 H-BIOC not effective not effective not effective 
 H-ZBIO effective partially effective partially effective 
     
Medium Concentration M-Con not effective not effective not effective 
 M-BST partially effective not effective not effective 
 M-BB12 effective partially effective not effective 
 M-BIOA effective effective not effective 
 M-BIOB effective partially effective not effective 
 M-BIOC partially effective not effective not effective 
 M-ZBIO effective effective partially effective 
     
Low Concentration L-Con not effective not effective partially effective 
 L-BST effective not effective not effective 
 L-BB12 effective effective not effective 
 L-ABST effective effective not effective 
a  Effective = removal to below the MCL; partially effective = >50% decrease in the maximum concentration; not effective = 
<50% decrease in the maximum concentration.    
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Table 4.3  Summary of percent removals of CT, CF, DCM, 1,2-DCA, and 1,1,2-
TCA a for Site B. 
Treatment 
Incubation 
Time CT CF DCM 1,2-DCA 
1,1,2-
TCA 
AC 716 29.6±7.1 20.8±1.4 + 28.5±3.1 43.7±9.6 
CON 757 33.2±19.3 57.5±12.2 40.2±12.4 67.2±4.5 70.5±4.6 
BST 757 97.7±2.9 71.6±3.1 26.8±15.8 76.4±2.4 80.8±2.7 
BB12 757 98.8±2.1 66.5±7.7 22.4±12.1 71.8±3.5 74.0±4.0 
BIO 757 100.0±0.0 76.7±2.8 57.1±9.6 77.6±4.1 82.3±3.6 
a Average of triplicates ± one standard deviation.   b + indicates an increase occurred relative to 






Table 4.4  Summary of treatment effectiveness of removing CT, CF and DCMa for 
Site B .  
Treatment CT CF DCM 
Con not effective partially effective not effective 
BST partially effective partially effective not effective 
BB12 partially effective partially effective not effective 
BIO effective partially effective partially effective 
a Effective = removal to below the MCL; partially effective = >50% decrease in the 










































































































































Figure 3.2  Behavior of the SRB culture (a) for the enrichment bottle, and (b) for 




































Figure 3.3  Behavior of the DCM culture (a) for the enrichment bottle, and (b) for 





























































Figure 4.1  Results for Site A, high concentration plume, autoclaved control treatment (average of triplicate 
microcosms; error bars indicate one standard deviation). 
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Figure 4.2  Results for Site A, high concentration plume, water control treatment (average of triplicate microcosms; 



























































CT CF DCM CM CS2 CH4 Ethylbenzene Toluene
Figure 4.3  Results for Site A, high concentration plume, unamended treatment (average of triplicate microcosms; 




























































CT CF DCM CM CS2 CH4 Ethylbenzene Toluene
Figure 4.4  Results for Site A, high concentration plume, biostimulation with corn syrup (average of triplicate 

























































CT CF DCM CM CS2 CH4 Ethylbenzene Toluene
Figure 4.5  Results for Site A, high concentration plume, biostimulation with corn syrup + B12 (average of triplicate 
























































CT CF DCM CM CS2 CH4 Ethylbenzene Toluene
Figure 4.6  Representative results for Site A, high concentration plume, bioaugmentation treatment A (bottle #3);       




Figure 4.7  Representative results for Site A, high concentration plume, bioaugmentation treatment B (average of 
triplicate microcosms; error bars indicate one standard deviation);    = adition of lactate;      = addition of B12;      = 












































































































CT CF DCM CM CS2 CH4 Ethylbenzene Toluene
Figure 4.8  Representative results for Site A, high concentration plume, bioaugmentation treatment C (average of 
triplicate microcosms; error bars indicate one standard deviation);     = adition of lactate;     = addition of B12;      = 





































































CT CF DCM CM
CS2 CH4 1,2-DCA Ethene
Ethane Ethylbenzene Toluene
C1                                        C2       C3 C4C2 C2 
E1                            E1 E2
Figure 4.9  Representative results for Site A, high concentration plume, ZVI + bioaugmentation treatment (bottle 
#1);    = addition of ZVI;    = addition of electron donor (E1 = lactate, E2 = corn syrup);    = addition of B12;     = 
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Figure 4.10  Performance of all treatments on CT, CF and DCM for Site A, high 
concentration plume; Con = unamended control; BST = biostimulation; BB12 = 
biostimulation + B12; BIOA = bioaugmentation with DHM-1; BIOB = 
bioaugmentation with SDC-9; BIOC = bioaugmentation with SRB; ZBIO = ZVI 
































































CT CF DCM CM CH4 CS2 Toluene
Figure 4.11  Results for Site A, medium concentration plume, autoclaved control treatment (average of triplicate 

























































CT CF DCM CM CH4 CS2 Toluene
Figure 4.12  Results for Site A, medium concentration plume, unamended treatment (average of triplicate 

























































CT CF DCM CM CH4 CS2 Toluene
Figure 4.13  Results for Site A, medium concentration plume, biostimulation with corn syrup (average of triplicate 


























































CT CF DCM CM CH4 CS2 Toluene
Figure 4.14  Representative results for Site A, medium concentration plume, biostimulation with corn syrup + B12 



























































CT CF DCM CM CH4 CS2 Toluene
C1 C1 C2
Figure 4.15  Representative results for Site A, medium concentration plume, bioaugmentation treatment A (bottle 




























































CT CF DCM CM CH4 CS2 Toluene
C1 C1 C2
Figure 4.16  Representative results for Site A, medium concentration plume, bioaugmentation treatment B (bottle 




























































CT CF DCM CM CH4 CS2 Toluene
Figure 4.17  Representative results for Site A, medium concentration plume, bioaugmentation treatment C (bottle 















































































CT CF DCM CM
1,2-DCA Ethene Ethane CH4
CS2 Ethylbenzene Toluene
C1                    C2    C2 C3   C2                                                            C2 
Figure 4.18  Representative results for Site A, medium concentration plume, ZVI + bioaugmentation treatment 
(bottle #2);    = addition of ZVI;     = addition of lactate;      = addition of B12;     = addition of cultures (C1 = SDC-9, 
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Figure 4.19  Performance of all treatments on CT, CF and DCM for Site A, 
medium concentration plume; Con = unamended control; BST = biostimulation; 
BB12 = biostimulation + B12; BIOA = bioaugmentation with DHM-1; BIOB = 
bioaugmentation with SDC-9; BIOC = bioaugmentation with SRB; ZBIO = ZVI 














































CT CF DCM CM CH4 CS2
Figure 4.20  Results for Site A, low concentration plume, autoclaved control treatment (average of triplicate 













































CT CF DCM CM CH4 CS2
Figure 4.21  Results for Site A, low concentration plume, unamended treatment (average of triplicate microcosms; 














































CT CF DCM CM CH4 CS2
Figure 4.22  Results for Site A, low concentration plume, biostimulation with corn syrup (average of triplicate 






















































CT CF DCM CM CH4 CS2
Figure 4.23  Results for Site A, low concentration plume, biostimulation with corn syrup + B12 (average of triplicate 




















































CT CF DCM CM CH4 CS2
Figure 4.24  Results for Site A, low concentration plume, biostimulation with pH-adjusted groundwater + corn syrup 
+ B12 (average of triplicate microcosms; error bars indicate one standard deviation);     = addition of corn syrup;    = 











































Figure 4.25  Performance of all treatments on CT, CF and DCM for Site A, low 
concentration plume; Con = unamended control; BST = biostimulation; BB12 = 
biostimulation + B12; AC = autoclaved control; ABST= biostimulation with ph-



























CT CF DCM 1,2-DCA 1,1,2-TCA
Figure 4.26  Results for Site B, autoclaved control treatment (average of triplicate microcosms; results for individual 



























CT CF DCM 1,2-DCA 1,1,2-TCA
Figure 4.27  Results for Site B, unamended treatment (average of triplicate microcosms; results for individual bottles 





























CT CF DCM 1,2-DCA 1,1,2-TCA
Figure 4.28  Results for Site B, biostimulation with corn syrup (average of triplicate microcosms; results for 






























CT CF DCM 1,2-DCA 1,1,2-TCA
Figure 4.29  Results for Site B, biostimulation with corn syrup + B12 (average of triplicate microcosms; results for 




























CT CF DCM 1,2-DCA 1,1,2-TCA
Figure 4.30  Results for Site B, bioaugmentation treatment (average of triplicate microcosms; results for individual 



























































Figure 4.31  Sulfate consumption of all active treatments for Site B (a) for sulfate 
concentration, and (b) for cumulative sulfate consumption; Con = unamende 
control; BST = biostimulation; BB12 = biostimulation + B12; BIO = 













































































Figure 4.32  Performance of all treatments on CT, CF and DCM for Site B; Con 
= unamended control; BST = biostimulation; BB12 = biostimulation + B12; BIO = 








































mol B12 /mol CFo
Figure 4.33  The effect of vitamin B12 concentration on maximum CF 
transformation rates by DHM-1 (a) for performances of all treatments with 
different B12 concentrations, and (b) for transformation rate of CF at different 


























































CF rate lag time
Figure 4.34  Impact of pH on biodegradation rates for CF by DHM-1 and the 
length of the lag phase prior to the onset of biodegradation. Error bars in both 
directions indicate the 95% confidence interval, based on results from triplicate 




















































Appendix A GC Standards and Response Factors 








(µmol/btl to µM)  
Conversion 
Factorb 
(µmol/btl to mg/L) 
Methanec 0.50 3.9810E-06 9.9030E-01 0.00850 0.00014 
Ethene 0.68 1.9145E-06 9.9958E-01 1.30419 0.03652 
Ethane 0.80 1.7632E-06 9.9961E-01 0.56731 0.01702 
CMc 1.22 1.2840E-05 9.9610E-01 12.32774 0.62243 
DCMc 4.60 3.1360E-05 9.9750E-01 17.24790 1.46486 
CS2
c 5.40 7.4900E-04 9.9490E-01 7.75632 0.59050 
CFc 7.16 2.4690E-05 9.9910E-01 15.81607 1.88812 
1,2-DCAd 7.50 2.1618E-05 9.9960E-01 18.06492 1.78770 
CTc 8.60 8.7800E-06 9.9890E-01 6.21792 0.95644 
1,1,2-TCAd 10.60    5.0000E-06  - 18.75165 2.50157 
Toluene 16.50 1.8000E-06 9.9930E-01 13.21717 1.21785 
Ethylbenzene 23.00 1.5644E-06 9.9740E-01 12.67880 1.34623 
a PAU = peak area units; btl = bottle.  
b Based on liquid volume of 50 mL and gas volume of 99 mL at 23ºC. 
c Determined by Shan (38). 















Figure A.1  GC FID response factor curves for ethane (a) and ethene (b); 50 mL 











(µmol/btl to mg/L) 
CMc 1.22 1.2210E-05 0.42480 
CS2 5.40 7.2230E-04 0.51497 
DCM 4.60 5.3150E-05 0.81013 
CF 7.16 3.3332E-05 1.10520 
a PAU = peak area units.  
b Based on liquid volume of 100 mL and gas volume of 60 mL at 23ºC. 






























































Figure A.2  GC FID response factor curves for CF (a), DCM (b), and CS2 (c); 100 





Appendix B HPLC Standards and Response Factors 
Table B.1  HPLC response factor for acetate, propionate, and lactate on an 
Aminex® HPX-87H ion exclusion column. 
Date of 
Results 










10/29/2009 6.197E-06 0.99999 5.066E-06 0.99998 3.031E-06 0.99996 





Figure B.1  HPLC response factor curves for acetate (a), propionate (b), and lactte 




















































Appendix C IC Standards and Response Factors 







8/18/2010 0.1078 0.9992 
9/6/2010 0.1308 0.9909 




























































Appendix D Media Protocol 
D.1 Preparation of medium for the  DHM-1 
Solutions needed for media: 
 
-Trace Metal Solution 
In a 1 L volumetric flask, add 1500 mg of FeCl2·4H2O, 190 mg of CoCl2·6H2O, 
100 mg of MnCl2·4H2O, 70 mg of ZnCl2, 6 mg of H3BO4, 36 mg of 
Na2MoO4·2H2O, 24 mg of NiCl2·6H2O, and 2 mg of CuCl2·2H2O. Then fill to 1 L 
with DDI water. 
-Selenite Solution 
In a 1 L volumetric flask, add 3 mg of Na2SeO3 and 5 mg of NaHCO3.  Then fill 
to 1 L with DDI water. 
-Ferrous Solution 
In a 1 L volumetric flask, add 3 mg of FeCl2·4H2O and 5 mg of NaHCO3.  Then 
fill to 1 L with DDI water. 
-Redox Solution 
In a 100 mL volumetric flask, add 0.1 g resazurin.  Then fill to 100 mL with DDI 
water. 
-Yeast Extract Solution 




In a 1 L volumetric flask, add 300 mg of NH4Cl, 300 mg of KCl, 150 mg of CaCl2·2H2O, 
400 mg of MgCl2·6H2O, 410 mg of K2HPO4, 4 g of NaHCO3, 1 mL of trace metal 
solution, 1 mL of selenite solution, 1 mL of ferrous solution, 1 mL of redox solution, and 
1 mL of sterilized yeast extract solution.  Then fill to 1 L with autoclaved DDI water. 
Transfer to 1 L bottle and purge with 30% CO2 and 70% N2 for a few minutes until 
complete dissolution of mineral salts. Add 120 mg of Na2S·9H2O crystals that have been 
rinsed and blotted dry with Kimwipes in a completely anaerobic chamber and allow 
solution to turn from blue to clear. 
 
D.2 Preparation of medium for the SRB culture 
Solutions needed for media: 
 
-Trace Metal Solution 
In a 1 L volumetric flask, add 1500 mg of FeCl2·4H2O, 190 mg of CoCl2·6H2O, 
100 mg of MnCl2·4H2O, 70 mg of ZnCl2, 6 mg of H3BO4, 36 mg of 
Na2MoO4·2H2O, 24 mg of NiCl2·6H2O, and 2 mg of CuCl2·2H2O. Then fill to 1 L 




In a 1 L volumetric flask, add 3 mg of Na2SeO3 and 5 mg of NaHCO3.  Then fill 
to 1 L with DDI water. 
-Ferrous Solution 
In a 1 L volumetric flask, add 3 mg of FeCl2·4H2O and 5 mg of NaHCO3.  Then 
fill to 1 L with DDI water. 
-Redox Solution 
In a 100 mL volumetric flask, add 0.1 g resazurin.  Then fill to 100 mL with DDI 
water. 
-Yeast Extract Solution 




In a 1 L volumetric flask, add 300 mg of NH4Cl, 300 mg of KCl, 150 mg of CaCl2·2H2O, 
400 mg of MgCl2·6H2O, 410 mg of K2HPO4, 4 g of NaHCO3, 5.268 g of Na2SO4, 1 mL 
of trace metal solution, 1 mL of selenite solution, 1 mL of ferrous solution, 1 mL of redox 
solution, and 1 mL of sterilized yeast extract solution.  Then fill to 1 L with autoclaved 
DDI water. Transfer to 1 L bottle. Add 120 mg of Na2S·9H2O crystals that have been 
rinsed and blotted dry with Kimwipes in a completely anaerobic chamber and allow 
solution to turn from blue to clear. 
 
D.3 Preparation of medium for the DCM culture 
Solutions needed for media: 
 
- Phosphate buffer 
In a 100 mL volumetric flask add 5.25 g K2HPO4.  Then fill to 100 mL with DDI 
water. 
- Salt solution 
In a 100 mL volumetric flask add 5.35 g NH4Cl, 0.46976 g CaCl2:2H2O, and 
0.17787 g FeCl2:H2O.  Then fill to 100 mL with DDI water. 
- Trace metals solution 
In a 100 mL volumetric flask add 0.03 g H3BO3, 0.0211 g ZnSO4:7H2O, 0.075 g 
NiCl2:6H2O, 0.1 g MnCl2:4H2O, 0.01 g CuCl2:2H2O, 0.15 g CoCl2:6H2O, 0.002 g 
Na2SeO3, 0.01 g Al2(SO4)3:16H2O, and 1 mL concentrated HCl.  Then fill to 100 
mL with DDI water. 
- Magnesium sulfate solution 
In a 100 mL volumetric flask add 6.25 g MgSO4:7H2O.  Then fill to 100 mL with 
DDI water. 
- Bicarbonate solution 
In a 500 mL volumetric flask add 8.0 g NaHCO3.  Then fill to 500 mL with DDI 
water. 
- Redox solution 
104 
 
In a 10 mL volumetric flask add 0.01 g resazurin.  Then fill to 10 mL with DDI 
water. 
- Ferrous sulfide solution 
To be added directly to autoclaved media after adding filter-sterilized solutions 
and placing in glove box.  For 1 L, weigh out 0.24g of Na2S:9H2O and 0.1448g 
FeCl2:H2O based on stock concentrations of 24 g/L and 14.48 g/L, into separate 
vials.  Add the Na2S:9H2O and allow media to clear.  Add the FeCl2:H2O and 
rinse both vials out with the 10 mL of autoclaved DDI water needed to balance 
the solution and add to the media. 
-Yeast extract solution 




 In a 1 L bottle add 10 mL phosphate solution, 10 mL salt solution, 2 mL trace 
metals solution, 2 mL magnesium sulfate solution, 1 mL redox solution, and 905 mL DDI 
water.  Autoclave this solution, and then add 50 mL filter sterilized bicarbonate solution 





























































CT CF DCM CM CS2 CH4 Ethylbenzene Toluene
Figure E.1  Results for Site A, high concentration plume, bioaugmentation treatment A (bottle #1);    =  addition of 

























































CT CF DCM CM CS2 CH4 Ethylbenzene Toluene
Figure E.2  Results for Site A, high concentration plume, bioaugmentation treatment A (bottle #2);    = addition of 






































































CT CF DCM CM
CS2 CH4 1,2-DCA Ethene
Ethane Ethylbenzene Toluene
C1                                        C2       C3 C4C2 C2 
E1                            E1 E2
Figure E.3  Results for Site A, high concentration plume, ZVI + bioaugmentation treatment (bottle #2);    = addition 
of ZVI;    = addition of electron donor (E1 = lactate, E2 = corn syrup);    = addition of B12;     = addition of cultures 





































































CT CF DCM CM
CS2 CH4 1,2-DCA Ethene
Ethane Ethylbenzene Toluene
C1                                        C2       C3 C4C2 C2 
E1                            E1 E2
Figure E.4  Results for Site A, high concentration plume, ZVI + bioaugmentation treatment (bottle #3);    = addition 
of ZVI;    = addition of electron donor (E1 = lactate, E2 = corn syrup);    = addition of B12;     = addition of cultures 


























































CT CF DCM CM CH4 CS2 Toluene
Figure E.5  Results for Site A, medium concentration plume, biostimulation with corn syrup + B12 (bottle #1);      = 



























































CT CF DCM CM CH4 CS2 Toluene
Figure E.6  Results for Site A, medium concentration plume, biostimulation with corn syrup + B12 (bottle #3);      = 




























































CT CF DCM CM CH4 CS2 Toluene
C1 C1 C2
Figure E.7  Results for Site A, medium concentration plume, bioaugmentation treatment A (bottle #1);      =  addition 




























































CT CF DCM CM CH4 CS2 Toluene
C1 C1 C2
Figure E.8  Results for Site A, medium concentration plume, bioaugmentation treatment A (bottle #3);      =  addition 





























































CT CF DCM CM CH4 CS2 Toluene
Figure E.9  Results for Site A, medium concentration plume, bioaugmentation treatment B (bottle #1);      =  addition 





























































CT CF DCM CM CH4 CS2 Toluene
C1 C1 C2
Figure E.10  Results for Site A, medium concentration plume, bioaugmentation treatment B (bottle #3);    =  addition 





























































CT CF DCM CM CH4 CS2 Toluene
Figure E.11  Results for Site A, medium concentration plume, bioaugmentation treatment C (bottle #2);       =  





























































CT CF DCM CM CH4 CS2 Toluene
Figure E.12  Results for Site A, medium concentration plume, bioaugmentation treatment C (bottle #3);       =  
















































































CT CF DCM CM
1,2-DCA Ethene Ethane CH4
CS2 Ethylbenzene Toluene
C1                    C2    C2 C3   C2                                                            C2 
Figure E.13  Results for Site A, medium concentration plume, ZVI + bioaugmentation treatment (bottle #1);    = 
addition of ZVI;     = addition of lactate;      = addition of B12;     = addition of cultures (C1 = SDC-9, C2 = DCM, and 














































































CT CF DCM CM
1,2-DCA Ethene Ethane CH4
CS2 Ethylbenzene Toluene
C1                    C2    C2 C3   C2                                                            C2 
Figure E.14  Results for Site A, medium concentration plume, ZVI + bioaugmentation treatment (bottle #3);    = 
addition of ZVI;     = addition of lactate;      = addition of B12;     = addition of cultures (C1 = SDC-9, C2 = DCM, and 










Figure F.1  Sample chromatograms for treatments H-CON (a), H-BIOA (b), 





1 = Methane   4 = CS2    7 = CT 
2 = Ethane   5 = CF    8 = Toluene 
3 = DCM   6 = 1,2-DCA   9 = Ethylbenzene 
 1 2       3  4        56                     8               9 
 1 2       3  4      5     7               8                             9 
 1 2       3  4      5     7                8              9 
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Appendix G Groundwater Withdrawal Impacts on GC Response Factors for Site B 
 In the description of results for Site B (Section 4.2), it was mentioned that  
repeated withdrawals of groundwater (to measure sulfate) made it n cessary to add 
groundwater in order to restore the balance between the liquid volume and headspace 
volume.  The impact of decreasing the liquid volume on the GC response factors for the 
primary volatile organic compounds was calculated, based on the distribut on of mass 
between the headspace and liquid phases and the subsequent change in the gas p ase 
concentration.  Table G.1 shows the percent difference in gas phase conc ntration 
between the bottle at the correct headspace and liquid volumes and the bottle after the 
maximum amount of groundwater was withdrawn.  There was less than a 1% impact on 





Table G.1  Summary of percent changes on the GC response factors of CT, CF, 




(mL) CT CF DCM 1,2-DCA 1,1,2-TCA 
AC-1 8 0.6% 12.3% 14.5% 15.8% 16.9% 
AC-2 8 0.6% 12.3% 14.5% 15.8% 16.9% 
AC-3 8 0.6% 12.3% 14.5% 15.8% 16.9% 
CON-1 7 0.5% 10.6% 12.5% 13.6% 14.5% 
CON-2 7 0.5% 10.6% 12.5% 13.6% 14.5% 
CON-3 6 0.4% 8.9% 10.5% 11.4% 12.2% 
BST-1 8 0.6% 12.3% 14.5% 15.8% 16.9% 
BST-2 8 0.6% 12.3% 14.5% 15.8% 16.9% 
BST-3 8 0.6% 12.3% 14.5% 15.8% 16.9% 
BB12-1 6 0.4% 8.9% 10.5% 11.4% 12.2% 
BB12-2 7 0.5% 10.6% 12.5% 13.6% 14.5% 
BB12-3 7 0.5% 10.6% 12.5% 13.6% 14.5% 
BIO-1 6 0.4% 8.9% 10.5% 11.4% 12.2% 
BIO-2 6 0.4% 8.9% 10.5% 11.4% 12.2% 
BIO-3 6 0.4% 8.9% 10.5% 11.4% 12.2% 
  
GC Response Factor Percent Change 
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Figure H.1  CF transformation by DHM-1 when B12 concentration is 0% in bottle 









































Figure H.2  CF transformation by DHM-1 when B12 concentration is 0.15% in 










































Figure H.3  CF transformation by DHM-1 when B12 concentration is 0.3% in 










































Figure H.4  CF transformation by DHM-1 when B12 concentration is 0.6% in 









































Figure H.5  CF transformation by DHM-1 when B12 concentration is 1% in bottle 









































Figure H.6  CF transformation by DHM-1 when B12 concentration is 3% in bottle 









































Figure H.7  CF transformation in medium control bottle 1 (a), bottle 2 (b), and 














































Figure I.1  CF transformation by DHM-1 when pH is 5.0 in bottle 1 (a), bottle 2 










































Figure I.2  CF transformation by DHM-1 when pH is 5.5 in bottle 1 (a), bottle 2 









































Figure I.3  CF transformation by DHM-1 when pH is 6.0 in bottle 1 (a), bottle 2 









































Figure I.4  CF transformation by DHM-1 when pH is 6.5 in bottle 1 (a), bottle 2 









































Figure I.5  CF transformation by DHM-1 when pH is 7.0 in bottle 1 (a), bottle 2 









































Figure I.6  CF transformation by DHM-1 when pH is 7.5 in bottle 1 (a), bottle 2 










































Figure I.7  CF transformation by DHM-1 when pH is 8.0 in bottle 1 (a), bottle 2 









































Figure I.8  CF transformation by DHM-1 in regular transfers bottle 1 (a), bottle 2 









Figure J.1  Results for Site B, autoclaved control bottle 1 (a), bottle 2 (b), and 













































































































































































































Figure J.2  Results for Site B, unamended treatment bottle 1 (a), bottle 2 (b), and 












































































































Figure J.3  Results for Site B, biostimulation with corn syrup bottle 1 (a), bottle 2 
















































































































Figure J.4  Results for Site B, biostimulation with corn syrup + B12 bottle 1 (a), 












































































































Figure J.5  Results for Site B, bioaugmentation bottle 1 (a), bottle 2 (b), and 
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